country,Region,lat,long,displayName,layerName,layerTitle,year,value,study.id,substudy.number,site,study.start.year,study.end.year,mutation,tested,present,Mixed.present,authors,publication.year,publication.Url,title,notes,pubMedId,marker.group,percentage,Mixed.percentage,included.or.excluded,PR,Prev_DR
Afghanistan,Asia,34.43,70.45,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.00006537373701576144,438,5,Jalalabad,2010,2011,dhfr 108N,71,71,71,"Awab GR, Imwong M, Pukrittayakamee S, Alim F, Hanpithakpong W, Tarning J, Dondorp AM, Day NP, White NJ, Woodrow CJ",2016,http://www.ncbi.nlm.nih.gov/pubmed/?term=26917051,Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction.,NA,26917051,dhfr 108N,100,100,NA,0.00653737370157614,100
Angola,Southern Africa,-8.84,13.23,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2007,0.06536883860826492,747,1,Luanda,2007,2007,dhfr 108N,61,61,61,"Gama BE, Pereira-Carvalho GA, Lutucuta Kosi FJ, Almeida de Oliveira NK, Fortes F, Rosenthal PJ, do Rosário VE, Daniel-Ribeiro CT, de Fátima Ferreira-da-Cruz M.",2011,https://www.ncbi.nlm.nih.gov/pubmed/?term=21864379,"Molecular markers of antifolate resistance in Plasmodium falciparum isolates from Luanda, Angola.",NA,21864379,dhfr 108N,100,100,NA,6.536883860826492,100
Angola,Southern Africa,-12.35,14.78,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.07064110785722733,25889865,1,Balombo,2010,2011,dhfr 108N,58,56,56,Foumane Ngane V,2015,http://www.ncbi.nlm.nih.gov/pubmed/25889865,"Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola.",NA,25889865,dhfr 108N,97,97,NA,7.0641107857227325,96.55172413793105
Angola,Southern Africa,-8.84,13.23,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2013,0.0664810910820961,736,2,NA,2013,2016,dhfr 108N,69,68,68,"Xu C, Sun H, Wei Q, Li J, Xiao T, Kong X, Wang Y, Zhao G, Wang L, Liu G, Yan G, Huang B, Yin K.",2019,https://www.ncbi.nlm.nih.gov/pubmed/?term=30803964,Mutation Profile of pfdhfr and pfdhps in Plasmodium falciparum among Returned Chinese Migrant Workers from Africa.,NA,30803964,dhfr 108N,99,99,I,6.64810910820961,98.55072463768116
Angola,Southern Africa,-9.55,16.33,NA,NA,NA,2007,NA,742,4,Malanje,2007,2007,dhfr 108N,128,127,127,"Fortes F, Dimbu R, Figueiredo P, Neto Z, do Rosário VE, Lopes D.",2011,https://www.ncbi.nlm.nih.gov/pubmed/?term=21288345,Evaluation of prevalence's of pfdhfr and pfdhps mutations in Angola.,NA,21288345,dhfr 108N,99,99,NA,NA,99.21875
Angola,Southern Africa,-8.92,14.87,NA,NA,NA,2007,NA,742,3,Kwanza Norte,2007,2007,dhfr 108N,68,68,68,"Fortes F, Dimbu R, Figueiredo P, Neto Z, do Rosário VE, Lopes D.",2011,https://www.ncbi.nlm.nih.gov/pubmed/?term=21288345,Evaluation of prevalence's of pfdhfr and pfdhps mutations in Angola.,NA,21288345,dhfr 108N,100,100,NA,NA,100
Angola,Southern Africa,-14.91,13.46,NA,NA,NA,2011,NA,433,1,Lubango,2011,2011,dhfr 108N,51,51,51,"Kaingona-Daniel EP, Gomes LR, Gama BE, Almeida-de-Oliveira NK, Fortes F, M<e9>nard D, Daniel-Ribeiro CT, Ferreira-da-Cruz Mde F",2016,http://www.ncbi.nlm.nih.gov/pubmed/?term=27267365,"Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.",NA,27267365,dhfr 108N,100,100,NA,NA,100
Benin,West Africa,9.35,2.62,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2012,0.24398840963840485,478,1,Parakou,2012,2012,dhfr 108N,194,35,35,"Ogouy<e8>mi-Hounto A, Ndam NT, Fad<e9>gnon G, Azagnandji C, Bello M, Moussiliou A, Chippaux JP, Kinde Gazard D, Massougbodji A",2013,http://www.ncbi.nlm.nih.gov/pubmed/?term=24225351,Low prevalence of the molecular markers of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in asymptomatic children in Northern Benin.,NA,24225351,dhfr 108N,18,18,I,24.398840963840485,18.04123711340206
Benin,West Africa,6.37,2.08,NA,NA,NA,2005,NA,21767415,0,Ouidah,2005,2008,dhfr 108N,59,54,54,"Gwladys Bertin,Val<e9>rie Briand, Diana Bonaventure, Ambre Carrieu, Achille Massougbodji, Michel Cot, and Philippe Deloron",2011,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3199903&tool=pmcentrez&rendertype=abstract,Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.,"Pregnant women_x000d_
Pfmdr1 copy number befo",21767415,dhfr 108N,92,92,NA,NA,91.52542372881356
Benin,West Africa,6.42,1.88,NA,NA,NA,2008,NA,512,1,NA,2008,2010,dhfr 108N,212,205,205,"Moussiliou A, De Tove YS, Doritchamou J, Luty AJ, Massougbodji A, Alifrangis M, Deloron P, Ndam NT",2013,http://www.ncbi.nlm.nih.gov/pubmed/?term=23758883,High rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in Benin.,Pregnant Women only,23758883,dhfr 108N,97,97,I,NA,96.69811320754717
Burkina Faso,West Africa,12.63,-3.72,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2000,0.8650988340377808,461,1,Bourasso,2000,2000,dhfr 108N,157,12,12,"Geiger C, Compaore G, Coulibaly B, Sie A, Dittmer M, Sanchez C, Lanzer M, J<e4>nisch T",2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24674355,Substantial increase in mutations in the genes pfdhfr and pfdhps puts sulphadoxine-pyrimethamine-based intermittent preventive treatment for malaria at risk in Burkina Faso.,NA,24674355,dhfr 108N,89,89,NA,86.50988340377808,7.643312101910828
Burkina Faso,West Africa,12.63,-3.72,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2009,0.6671504974365234,461,2,Bourasso,2009,2009,dhfr 108N,249,128,128,"Geiger C, Compaore G, Coulibaly B, Sie A, Dittmer M, Sanchez C, Lanzer M, J<e4>nisch T",2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24674355,Substantial increase in mutations in the genes pfdhfr and pfdhps puts sulphadoxine-pyrimethamine-based intermittent preventive treatment for malaria at risk in Burkina Faso.,NA,24674355,dhfr 108N,89,89,NA,66.71504974365234,51.40562248995983
Burkina Faso,West Africa,11.43,-4.04,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2009,0.6030772924423218,24733476,0,"Satiri, Balla, Kadomba",2009,2009,dhfr 108N,261,144,144,Som<e9> F,2014,http://www.ncbi.nlm.nih.gov/pubmed/24733476,Selection of Drug Resistance-Mediating Plasmodium falciparum Genetic Polymorphisms by Seasonal Malaria Chemoprevention in Burkina Faso.,Publication presents genotype prevalence pre-,24733476,dhfr 108N,55,55,I,60.30772924423218,55.172413793103445
Burkina Faso,West Africa,12.63,-3.72,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.7007732391357422,461,3,Bourasso,2010,2010,dhfr 108N,223,132,132,"Geiger C, Compaore G, Coulibaly B, Sie A, Dittmer M, Sanchez C, Lanzer M, J<e4>nisch T",2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24674355,Substantial increase in mutations in the genes pfdhfr and pfdhps puts sulphadoxine-pyrimethamine-based intermittent preventive treatment for malaria at risk in Burkina Faso.,NA,24674355,dhfr 108N,89,89,NA,70.07732391357422,59.19282511210763
Burkina Faso,West Africa,12.63,-3.72,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2011,0.7103868722915649,461,4,Bourasso,2011,2011,dhfr 108N,213,147,147,"Geiger C, Compaore G, Coulibaly B, Sie A, Dittmer M, Sanchez C, Lanzer M, J<e4>nisch T",2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24674355,Substantial increase in mutations in the genes pfdhfr and pfdhps puts sulphadoxine-pyrimethamine-based intermittent preventive treatment for malaria at risk in Burkina Faso.,NA,24674355,dhfr 108N,89,89,NA,71.0386872291565,69.01408450704226
Burkina Faso,West Africa,12.68,-2.19,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2012,0.469222754240036,445,1,Nanoro,2012,2012,dhfr 108N,225,142,142,"Tahita MC, Tinto H, Erhart A, Kazienga A, Fitzhenry R, VanOvermeir C, Rosanas-Urgell A, Ouedraogo JB, Guiguemde RT, Van Geertruyden JP, D'Alessandro U",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26368675,Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine.,Pregnant Women,26368675,dhfr 108N,63,63,NA,46.9222754240036,63.11111111111111
Burkina Faso,West Africa,11.18,-4.29,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2012,0.25342753529548645,497,1,Bobo-Dioulasso,2012,2012,dhfr 108N,235,150,150,"Som<e9> AF, Sorgho H, Zongo I, Bazi<e9> T, Niki<e9>ma F, Sawadogo A, Zongo M, Compaor<e9> YD, Ou<e9>draogo JB",2016,http://www.ncbi.nlm.nih.gov/pubmed/?term=28004634,"Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in parasites isolated from symptomatic malaria patients in Burkina Faso.",NA,28004634,dhfr 108N,64,64,I,25.342753529548645,63.82978723404256
Cameroon,Central Africa,4.09,9.31,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.6474341750144958,631,1,Mutengene,2003,2005,dhfr 108N,222,220,220,"Moyeh MN, Njimoh DL, Evehe MS, Ali IM, Nji AM, Nkafu DN, Masumbe PN, Barbara AT, Ndikum VN, Mbacham WF.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=29854394,"Effects of Drug Policy Changes on Evolution of Molecular Markers of Plasmodium falciparum Resistance to Chloroquine, Amodiaquine, and Sulphadoxine-Pyrimethamine in the South West Region of Cameroon.",NA,29854394,dhfr 108N,100,100,I,64.74341750144958,99.09909909909908
Cameroon,Central Africa,4.09,9.31,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2009,0.32457488775253296,631,2,Mutengene,2009,2013,dhfr 108N,243,243,243,"Moyeh MN, Njimoh DL, Evehe MS, Ali IM, Nji AM, Nkafu DN, Masumbe PN, Barbara AT, Ndikum VN, Mbacham WF.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=29854394,"Effects of Drug Policy Changes on Evolution of Molecular Markers of Plasmodium falciparum Resistance to Chloroquine, Amodiaquine, and Sulphadoxine-Pyrimethamine in the South West Region of Cameroon.",NA,29854394,dhfr 108N,100,100,I,32.457488775253296,100
Cameroon,Central Africa,3.87,11.52,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.12427136301994324,536,1,Yaound<e9>,2010,2011,dhfr 108N,51,50,50,"Chauvin P, Menard S, Iriart X, Nsango SE, Tchioffo MT, Abate L, Awono-Amb<e9>n<e9> PH, Morlais I, Berry A",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26080363,"Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaound<e9>, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles.",Prevalence from samples from pregnant women before IPTp displayed,26080363,dhfr 108N,98,98,NA,12.427136301994324,98.0392156862745
Central African Republic,Central Africa,4.37,18.58,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2002,0.6158406734466553,740,1,NA,2002,2005,dhfr 108N,139,137,137,"Amor A, Toro C, Fernández-Martínez A, Baquero M, Benito A, Berzosa P.",2012,https://www.ncbi.nlm.nih.gov/pubmed/?term=22462737,Molecular markers in plasmodium falciparum linked to resistance to anti-malarial drugs in samples imported from Africa over an eight-year period (2002-2010): impact of the introduction of artemisinin combination therapy.,NA,22462737,dhfr 108N,99,99,NA,61.58406734466553,98.56115107913668
Central African Republic,Central Africa,4.37,18.58,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2008,0.7803312540054321,740,2,NA,2008,2010,dhfr 108N,61,60,60,"Amor A, Toro C, Fernández-Martínez A, Baquero M, Benito A, Berzosa P.",2012,https://www.ncbi.nlm.nih.gov/pubmed/?term=22462737,Molecular markers in plasmodium falciparum linked to resistance to anti-malarial drugs in samples imported from Africa over an eight-year period (2002-2010): impact of the introduction of artemisinin combination therapy.,NA,22462737,dhfr 108N,99,99,NA,78.03312540054321,98.36065573770492
Chad,Central Africa,8.47,16.7,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2016,0.1604759842157364,607,1,Kom<e9>,2016,2016,dhfr 108N,180,176,176,"Suttipat Srisutham, Nguyen Than Thuy-Nhien, Ranitha Vongpromek, Teeradet Khomvarn, Mayfong Mayxay, Olivo Miotto, Francois Nosten, Frank Smithuis, Rob van der Pluijm, Lorenz von Seidlein, Carol H Sibley, Philippe J. Gu<e9>rin, Nicholas P. J. Day, Arjen Dondorp, Mehul Dhorda, Mallika Imwong",2016,NA,Antimalarial Drug Resistance Marker Prevalence Survey - 2016,NA,NA,dhfr 108N,98,98,NA,16.04759842157364,97.77777777777776
China,Asia,25.05,102.71,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2009,0,22839209,0,Yunnan,2009,2010,dhfr 108N,93,58,58,Huang F,2012,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3459721&tool=pmcentrez&rendertype=abstract,"Molecular epidemiology of drug resistance markers of Plasmodium falciparum in Yunnan Province, China.",Nearly alf of patients infected in Myanmar,22839209,dhfr 108N,62,62,NA,0,62.365591397849464
China,Asia,24.62,98,NA,NA,NA,2003,NA,523,2,Tengchong,2003,2008,dhfr 108N,92,92,92,"Zhang Y, Yan H, Wei G, Han S, Huang Y, Zhang Q, Pan W",2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24145550,Distinctive origin and spread route of pyrimethamine-resistant Plasmodium falciparum in southern China.,NA,24145550,dhfr 108N,100,100,NA,NA,100
China,Asia,24.45,98.59,NA,NA,NA,2003,NA,523,3,Dehong,2003,2008,dhfr 108N,78,78,78,"Zhang Y, Yan H, Wei G, Han S, Huang Y, Zhang Q, Pan W",2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24145550,Distinctive origin and spread route of pyrimethamine-resistant Plasmodium falciparum in southern China.,NA,24145550,dhfr 108N,100,100,NA,NA,100
China,Asia,24.75,97.58,NA,NA,NA,2003,NA,523,1,Lazan,2003,2008,dhfr 108N,60,60,60,"Zhang Y, Yan H, Wei G, Han S, Huang Y, Zhang Q, Pan W",2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24145550,Distinctive origin and spread route of pyrimethamine-resistant Plasmodium falciparum in southern China.,NA,24145550,dhfr 108N,100,100,NA,NA,100
Colombia,South America,1.81,-78.76,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2006,0.06611056625843048,529,1,Tumaco,2006,2008,dhfr 108N,58,38,38,"Hern<e1>ndez DC, Guerra AP, Cucunub<e1> ZM, Nicholls RS, Barrera SM",2013,http://www.ncbi.nlm.nih.gov/pubmed/?term=23714094,Haplotypes associated with resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum in two malaria endemic locations in Colombia.,NA,23714094,dhfr 108N,66,66,NA,6.611056625843048,65.51724137931035
Colombia,South America,8.17,-76.08,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2006,0.0011550370836630464,529,2,Tierralta,2006,2008,dhfr 108N,122,122,122,"Hern<e1>ndez DC, Guerra AP, Cucunub<e1> ZM, Nicholls RS, Barrera SM",2013,http://www.ncbi.nlm.nih.gov/pubmed/?term=23714094,Haplotypes associated with resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum in two malaria endemic locations in Colombia.,NA,23714094,dhfr 108N,100,100,NA,0.11550370836630464,100
Comoros,East Africa,-11.65,43.09,NA,NA,NA,2012,NA,443,1,"Grande Comore, Comores",2012,2013,dhfr 108N,123,115,115,"Papa Mze N, Ndiaye YD, Diedhiou CK, Rahamatou S, Dieye B, Daniels RF, Hamilton EJ, Diallo M, Bei AK, Wirth DF, Mboup S, Volkman SK, Ahouidi AD, Ndiaye D",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26415927,RDTs as a source of DNA to study Plasmodium falciparum drug resistance in isolates from Senegal and the Comoros Islands.,NA,26415927,dhfr 108N,94,94,NA,NA,93.4959349593496
Congo,Central Africa,-4.27,15.28,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.19172042608261108,737,1,Brazzaville,2005,2005,dhfr 108N,100,97,97,"Tsumori Y, Ndounga M, Sunahara T, Hayashida N, Inoue M, Nakazawa S, Casimiro P, Isozumi R, Uemura H, Tanabe K, Kaneko O, Culleton R.",2011,https://www.ncbi.nlm.nih.gov/pubmed/?term=21858115,"Plasmodium falciparum: differential selection of drug resistance alleles in contiguous urban and peri-urban areas of Brazzaville, Republic of Congo.",asymptomatic,21858115,dhfr 108N,97,97,NA,19.17204260826111,97
Democratic Republic of the Congo,Central Africa,-5.14,15.09,NA,NA,NA,2014,NA,713,4,Kisantu,2014,2015,dhfr 108N,450,449,449,"Nkoli Mandoko P, Rouvier F, Matendo Kakina L, Moke Mbongi D, Latour C, Losimba Likwela J, Ngoyi Mumba D, Bi Shamamba SK, Tamfum Muyembe JJ, Muepu Tshilolo L, Parzy D, Sinou V.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=30053021,Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in the Democratic Republic of the Congo: emergence of highly resistant pfdhfr/pfdhps alleles.,NA,30053021,dhfr 108N,100,100,NA,NA,99.77777777777776
Democratic Republic of the Congo,Central Africa,-4.35,15.23,NA,NA,NA,2014,NA,713,2,Binza Ozone,2014,2015,dhfr 108N,393,390,390,"Nkoli Mandoko P, Rouvier F, Matendo Kakina L, Moke Mbongi D, Latour C, Losimba Likwela J, Ngoyi Mumba D, Bi Shamamba SK, Tamfum Muyembe JJ, Muepu Tshilolo L, Parzy D, Sinou V.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=30053021,Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in the Democratic Republic of the Congo: emergence of highly resistant pfdhfr/pfdhps alleles.,NA,30053021,dhfr 108N,99,99,NA,NA,99.23664122137404
Democratic Republic of the Congo,Central Africa,-4.41,15.41,NA,NA,NA,2014,NA,713,1,Kingasani,2014,2015,dhfr 108N,407,404,404,"Nkoli Mandoko P, Rouvier F, Matendo Kakina L, Moke Mbongi D, Latour C, Losimba Likwela J, Ngoyi Mumba D, Bi Shamamba SK, Tamfum Muyembe JJ, Muepu Tshilolo L, Parzy D, Sinou V.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=30053021,Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in the Democratic Republic of the Congo: emergence of highly resistant pfdhfr/pfdhps alleles.,NA,30053021,dhfr 108N,99,99,NA,NA,99.26289926289928
Democratic Republic of the Congo,Central Africa,-5.56,14.44,NA,NA,NA,2014,NA,713,3,Kimpese,2014,2015,dhfr 108N,464,460,460,"Nkoli Mandoko P, Rouvier F, Matendo Kakina L, Moke Mbongi D, Latour C, Losimba Likwela J, Ngoyi Mumba D, Bi Shamamba SK, Tamfum Muyembe JJ, Muepu Tshilolo L, Parzy D, Sinou V.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=30053021,Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in the Democratic Republic of the Congo: emergence of highly resistant pfdhfr/pfdhps alleles.,NA,30053021,dhfr 108N,99,99,NA,NA,99.13793103448276
Equatorial Guinea,Central Africa,3.73,8.77,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2001,0.2652883529663086,806,2,NA,2001,2001,dhfr 108N,102,83,83,"Berzosa P, Molina de la Fuente I, Ta-Tang TH, Gonz<e1>lez V, Garc<ed>a L, Rodr<ed>guez-Galet A, D<ed>az-Rega<f1><f3>n R, Gal<e1>n R, Cerrada-G<e1>lvez L, Ncogo P, Riloha M, Benito A.",2021,https://pubmed.ncbi.nlm.nih.gov/34906159/,Temporal evolution of the resistance genotypes of Plasmodium falciparum in isolates from Equatorial Guinea during 20<a0>years (1999 to 2019).,NA,34906159,dhfr 108N,100,100,NA,26.52883529663086,81.37254901960785
Equatorial Guinea,Central Africa,3.73,8.77,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.22070395946502686,806,3,NA,2004,2005,dhfr 108N,262,257,257,"Berzosa P, Molina de la Fuente I, Ta-Tang TH, Gonz<e1>lez V, Garc<ed>a L, Rodr<ed>guez-Galet A, D<ed>az-Rega<f1><f3>n R, Gal<e1>n R, Cerrada-G<e1>lvez L, Ncogo P, Riloha M, Benito A.",2021,https://pubmed.ncbi.nlm.nih.gov/34906159/,Temporal evolution of the resistance genotypes of Plasmodium falciparum in isolates from Equatorial Guinea during 20<a0>years (1999 to 2019).,NA,34906159,dhfr 108N,100,100,NA,22.07039594650269,98.09160305343512
Equatorial Guinea,Central Africa,3.73,8.77,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2006,0.14527852833271027,806,4,NA,2006,2006,dhfr 108N,158,158,158,"Berzosa P, Molina de la Fuente I, Ta-Tang TH, Gonz<e1>lez V, Garc<ed>a L, Rodr<ed>guez-Galet A, D<ed>az-Rega<f1><f3>n R, Gal<e1>n R, Cerrada-G<e1>lvez L, Ncogo P, Riloha M, Benito A.",2021,https://pubmed.ncbi.nlm.nih.gov/34906159/,Temporal evolution of the resistance genotypes of Plasmodium falciparum in isolates from Equatorial Guinea during 20<a0>years (1999 to 2019).,NA,34906159,dhfr 108N,100,100,NA,14.527852833271028,100
Equatorial Guinea,Central Africa,3.73,8.77,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2011,0.12532754242420197,806,5,NA,2011,2011,dhfr 108N,163,163,163,"Berzosa P, Molina de la Fuente I, Ta-Tang TH, Gonz<e1>lez V, Garc<ed>a L, Rodr<ed>guez-Galet A, D<ed>az-Rega<f1><f3>n R, Gal<e1>n R, Cerrada-G<e1>lvez L, Ncogo P, Riloha M, Benito A.",2021,https://pubmed.ncbi.nlm.nih.gov/34906159/,Temporal evolution of the resistance genotypes of Plasmodium falciparum in isolates from Equatorial Guinea during 20<a0>years (1999 to 2019).,NA,34906159,dhfr 108N,100,100,NA,12.532754242420197,100
Equatorial Guinea,Central Africa,1.75,10.17,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2013,0.4214911162853241,475,3,Miyobo,2013,2013,dhfr 108N,104,104,104,"Guerra M, Neres R, Salgueiro P, Mendes C, Ndong-Mabale N, Berzosa P, de Sousa B, Arez AP",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=27795385,Plasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy.,NA,27795385,dhfr 108N,100,100,NA,42.14911162853241,100
Equatorial Guinea,Central Africa,1.86,9.77,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2013,0.24226097762584686,557,1,Bata,2013,2013,dhfr 108N,244,243,243,"Berzosa P, Esteban-Cantos A, Garc<ed>a L, Gonz<e1>lez V, Navarro M, Fern<e1>ndez T, Romay-Barja M, Herrador Z, Rubio JM, Ncogo P, Santana-Morales M, Valladares B, Riloha M, Benito A",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=28086777,"Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).",NA,28086777,dhfr 108N,100,100,NA,24.226097762584686,99.59016393442624
Equatorial Guinea,Central Africa,3.62,8.75,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2013,0.14711278676986694,725,1,Bioko Island,2013,2014,dhfr 108N,167,162,164,"Tingting Jiang, Jiangtao Chen, Hongxia Fu, Kai Wu, Yi Yao, Juan Urbano Monsuy Eyi, Rocio Apicante Matesa, Maximo Miko Ondo Obono, Weixing Du, Huabing Tan, Min Lin,Jian Li",2019,https://www.ncbi.nlm.nih.gov/pubmed/?term=30914041,"High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.",NA,30914041,dhfr 108N,97,98,NA,14.711278676986694,97.0059880239521
Equatorial Guinea,Central Africa,3.73,8.77,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2013,0.1667919158935547,806,6,NA,2013,2013,dhfr 108N,170,168,168,"Berzosa P, Molina de la Fuente I, Ta-Tang TH, Gonz<e1>lez V, Garc<ed>a L, Rodr<ed>guez-Galet A, D<ed>az-Rega<f1><f3>n R, Gal<e1>n R, Cerrada-G<e1>lvez L, Ncogo P, Riloha M, Benito A.",2021,https://pubmed.ncbi.nlm.nih.gov/34906159/,Temporal evolution of the resistance genotypes of Plasmodium falciparum in isolates from Equatorial Guinea during 20<a0>years (1999 to 2019).,NA,34906159,dhfr 108N,100,100,NA,16.67919158935547,98.82352941176472
Equatorial Guinea,Central Africa,3.75,8.71,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2013,0.19391986727714539,736,4,Malabo,2013,2016,dhfr 108N,80,79,79,"Xu C, Sun H, Wei Q, Li J, Xiao T, Kong X, Wang Y, Zhao G, Wang L, Liu G, Yan G, Huang B, Yin K.",2019,https://www.ncbi.nlm.nih.gov/pubmed/?term=30803964,Mutation Profile of pfdhfr and pfdhps in Plasmodium falciparum among Returned Chinese Migrant Workers from Africa.,NA,30803964,dhfr 108N,99,99,I,19.39198672771454,98.75
Equatorial Guinea,Central Africa,3.73,8.77,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2016,0.2304629683494568,806,7,NA,2016,2016,dhfr 108N,169,168,168,"Berzosa P, Molina de la Fuente I, Ta-Tang TH, Gonz<e1>lez V, Garc<ed>a L, Rodr<ed>guez-Galet A, D<ed>az-Rega<f1><f3>n R, Gal<e1>n R, Cerrada-G<e1>lvez L, Ncogo P, Riloha M, Benito A.",2021,https://pubmed.ncbi.nlm.nih.gov/34906159/,Temporal evolution of the resistance genotypes of Plasmodium falciparum in isolates from Equatorial Guinea during 20<a0>years (1999 to 2019).,NA,34906159,dhfr 108N,100,100,NA,23.04629683494568,99.40828402366864
Equatorial Guinea,Central Africa,3.73,8.77,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2019,0.2046331912279129,806,8,NA,2019,2019,dhfr 108N,139,139,139,"Berzosa P, Molina de la Fuente I, Ta-Tang TH, Gonz<e1>lez V, Garc<ed>a L, Rodr<ed>guez-Galet A, D<ed>az-Rega<f1><f3>n R, Gal<e1>n R, Cerrada-G<e1>lvez L, Ncogo P, Riloha M, Benito A.",2021,https://pubmed.ncbi.nlm.nih.gov/34906159/,Temporal evolution of the resistance genotypes of Plasmodium falciparum in isolates from Equatorial Guinea during 20<a0>years (1999 to 2019).,NA,34906159,dhfr 108N,100,100,NA,20.46331912279129,100
Equatorial Guinea,Central Africa,3.73,8.77,NA,NA,NA,1999,NA,806,1,NA,1999,1999,dhfr 108N,60,56,56,"Berzosa P, Molina de la Fuente I, Ta-Tang TH, Gonz<e1>lez V, Garc<ed>a L, Rodr<ed>guez-Galet A, D<ed>az-Rega<f1><f3>n R, Gal<e1>n R, Cerrada-G<e1>lvez L, Ncogo P, Riloha M, Benito A.",2021,https://pubmed.ncbi.nlm.nih.gov/34906159/,Temporal evolution of the resistance genotypes of Plasmodium falciparum in isolates from Equatorial Guinea during 20<a0>years (1999 to 2019).,NA,34906159,dhfr 108N,100,100,NA,NA,93.33333333333331
Ethiopia,East Africa,8.96,38.64,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0,442,1,Addis Ababa,2005,2005,dhfr 108N,63,58,59,"Tessema SK, Kassa M, Kebede A, Mohammed H, Leta GT, Woyessa A, Guma GT, Petros B",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26431464,Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia.,NA,26431464,dhfr 108N,92,94,NA,0,92.06349206349206
Ethiopia,East Africa,8.96,38.64,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2007,0,442,2,Addis Ababa,2007,2008,dhfr 108N,63,47,47,"Tessema SK, Kassa M, Kebede A, Mohammed H, Leta GT, Woyessa A, Guma GT, Petros B",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26431464,Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia.,NA,26431464,dhfr 108N,92,92,NA,0,74.60317460317461
Ethiopia,East Africa,7,39,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2007,0,738,1,West Arsi,2007,2009,dhfr 108N,76,76,76,"Patricia Mula, Amalia Fern<e1>ndez-Mart<ed>nez, Aida de Lucio, Jose Manuel Ramos, Francisco Reyes, Vicenta Gonz<e1>lez, Agust<ed>n Benito,Pedro Berzosa",2011,https://www.ncbi.nlm.nih.gov/pubmed/?term=21810256,Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia.,genes that showed mixed wild- type and mutant alleles were deemed to be mutant,21810256,dhfr 108N,100,100,I,0,100
Ethiopia,East Africa,11.58,37.38,NA,NA,NA,2005,NA,479,1,Bahir Dar,2005,2005,dhfr 108N,61,60,60,"Hailemeskel E, Kassa M, Taddesse G, Mohammed H, Woyessa A, Tasew G, Sleshi M, Kebede A, Petros B",2013,http://www.ncbi.nlm.nih.gov/pubmed/?term=24055717,"Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.",NA,24055717,dhfr 108N,99,98,NA,NA,98.36065573770492
Ethiopia,East Africa,11.58,37.38,NA,NA,NA,2008,NA,479,2,Bahir Dar,2008,2008,dhfr 108N,78,77,77,"Hailemeskel E, Kassa M, Taddesse G, Mohammed H, Woyessa A, Tasew G, Sleshi M, Kebede A, Petros B",2013,http://www.ncbi.nlm.nih.gov/pubmed/?term=24055717,"Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.",NA,24055717,dhfr 108N,99,99,NA,NA,98.71794871794872
Gabon,Central Africa,1.6,11.56,NA,NA,NA,2008,NA,436,2,Oyem,2008,2008,dhfr 108N,62,60,60,"Ndong Ngomo JM, Mawili-Mboumba DP, M'Bondoukwe NP, Niki<e9>ma Ndong Ella R, Bouyou Akotet MK",2016,http://www.ncbi.nlm.nih.gov/pubmed/?term=27190671,"Increased Prevalence of Mutant Allele Pfdhps 437G and Pfdhfr Triple Mutation in Plasmodium falciparum Isolates from a Rural Area of Gabon, Three Years after the Change of Malaria Treatment Policy.",Cross sectional study,27190671,dhfr 108N,100,100,NA,NA,96.7741935483871
Ghana,West Africa,7.15,0.46,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.23912055790424347,741,10,Hohoe,2003,2004,dhfr 108N,78,68,68,"Duah NO, Quashie NB, Abuaku BK, Sebeny PJ, Kronmann KC, Koram KA.",2012,https://www.ncbi.nlm.nih.gov/pubmed/?term=23045251,Surveillance of molecular markers of Plasmodium falciparum resistance to sulphadoxine-pyrimethamine 5 years after the change of malaria treatment policy in Ghana.,NA,23045251,dhfr 108N,87,87,I,23.912055790424347,87.17948717948718
Ghana,West Africa,6.45,-1.58,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2011,0.3827260434627533,656,1,Bekwai,2011,2012,dhfr 108N,139,122,122,"Osarfo J, Tagbor H, Magnussen P, Alifrangis M.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=29582732,Molecular Markers of Plasmodium falciparum Drug Resistance in Parasitemic Pregnant Women in the Middle Forest Belt of Ghana.,NA,29582732,dhfr 108N,88,88,I,38.27260434627533,87.76978417266187
Ghana,West Africa,6.39,-0.38,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2014,0.28794798254966736,780,1,Begoro,2014,2014,dhfr 108N,88,88,88,"Mensah BA, Aydemir O, Myers-Hansen JL, Opoku M, Hathaway NJ, Marsh PW, Anto F, Bailey J, Abuaku B, Ghansah A.",2020,https://pubmed.ncbi.nlm.nih.gov/31932374/,Antimalarial Drug Resistance Profiling of Plasmodium falciparum Infections in Ghana Using Molecular Inversion Probes and Next-Generation Sequencing.,NA,31932374,dhfr 108N,100,100,NA,28.794798254966736,100
Ghana,West Africa,5.11,-1.25,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2014,0.2705202102661133,780,5,Cape Coast,2014,2014,dhfr 108N,90,90,90,"Mensah BA, Aydemir O, Myers-Hansen JL, Opoku M, Hathaway NJ, Marsh PW, Anto F, Bailey J, Abuaku B, Ghansah A.",2020,https://pubmed.ncbi.nlm.nih.gov/31932374/,Antimalarial Drug Resistance Profiling of Plasmodium falciparum Infections in Ghana Using Molecular Inversion Probes and Next-Generation Sequencing.,NA,31932374,dhfr 108N,100,100,NA,27.052021026611328,100
Ghana,West Africa,6.39,-0.38,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2015,0.24114815890789032,780,2,Begoro,2015,2015,dhfr 108N,87,82,82,"Mensah BA, Aydemir O, Myers-Hansen JL, Opoku M, Hathaway NJ, Marsh PW, Anto F, Bailey J, Abuaku B, Ghansah A.",2020,https://pubmed.ncbi.nlm.nih.gov/31932374/,Antimalarial Drug Resistance Profiling of Plasmodium falciparum Infections in Ghana Using Molecular Inversion Probes and Next-Generation Sequencing.,NA,31932374,dhfr 108N,100,100,NA,24.114815890789032,94.2528735632184
Ghana,West Africa,5.11,-1.25,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2015,0.22429175674915314,780,1,Cape Coast,2015,2015,dhfr 108N,109,107,107,"Mensah BA, Aydemir O, Myers-Hansen JL, Opoku M, Hathaway NJ, Marsh PW, Anto F, Bailey J, Abuaku B, Ghansah A.",2020,https://pubmed.ncbi.nlm.nih.gov/31932374/,Antimalarial Drug Resistance Profiling of Plasmodium falciparum Infections in Ghana Using Molecular Inversion Probes and Next-Generation Sequencing.,NA,31932374,dhfr 108N,100,100,NA,22.429175674915314,98.1651376146789
Ghana,West Africa,6.39,-0.38,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2016,0.1938316971063614,780,3,Begoro,2016,2016,dhfr 108N,79,76,76,"Mensah BA, Aydemir O, Myers-Hansen JL, Opoku M, Hathaway NJ, Marsh PW, Anto F, Bailey J, Abuaku B, Ghansah A.",2020,https://pubmed.ncbi.nlm.nih.gov/31932374/,Antimalarial Drug Resistance Profiling of Plasmodium falciparum Infections in Ghana Using Molecular Inversion Probes and Next-Generation Sequencing.,NA,31932374,dhfr 108N,100,100,NA,19.38316971063614,96.20253164556962
Ghana,West Africa,5.11,-1.25,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2016,0.1707802414894104,780,2,Cape Coast,2016,2016,dhfr 108N,84,84,84,"Mensah BA, Aydemir O, Myers-Hansen JL, Opoku M, Hathaway NJ, Marsh PW, Anto F, Bailey J, Abuaku B, Ghansah A.",2020,https://pubmed.ncbi.nlm.nih.gov/31932374/,Antimalarial Drug Resistance Profiling of Plasmodium falciparum Infections in Ghana Using Molecular Inversion Probes and Next-Generation Sequencing.,NA,31932374,dhfr 108N,100,100,NA,17.07802414894104,100
Ghana,West Africa,5.55,-0.2,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2016,0.08756301552057266,781,3,NA,2016,2018,dhfr 108N,154,121,121,"Zhao L, Pi L, Qin Y, Lu Y, Zeng W, Xiang Z, Qin P, Chen X, Li C, Zhang Y, Wang S, Si Y, Yang G, Rosenthal BM, Huang Y, Yang Z.",2020,https://pubmed.ncbi.nlm.nih.gov/31809965/,Widespread resistance mutations to sulfadoxine-pyrimethamine in malaria parasites imported to China from Central and Western Africa.,Migrant workers returned to China from African countries,31809965,dhfr 108N,79,79,NA,8.756301552057266,78.57142857142857
Ghana,West Africa,6.39,-0.38,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2017,0.15797333419322968,780,4,Begoro,2017,2017,dhfr 108N,61,61,61,"Mensah BA, Aydemir O, Myers-Hansen JL, Opoku M, Hathaway NJ, Marsh PW, Anto F, Bailey J, Abuaku B, Ghansah A.",2020,https://pubmed.ncbi.nlm.nih.gov/31932374/,Antimalarial Drug Resistance Profiling of Plasmodium falciparum Infections in Ghana Using Molecular Inversion Probes and Next-Generation Sequencing.,NA,31932374,dhfr 108N,100,100,NA,15.797333419322968,100
Ghana,West Africa,9.56,-0.95,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2017,0.06662958860397339,759,2,Pagaza,2017,2017,dhfr 108N,52,52,52,"Dieng CC, Gonzalez L, Pestana K, Dhikrullahi SB, Amoah LE, Afrane YA, Lo E.",2019,https://www.ncbi.nlm.nih.gov/pubmed/?term=31315304,Contrasting Asymptomatic and Drug Resistance Gene Prevalence of Plasmodium falciparum in Ghana: Implications on Seasonal Malaria Chemoprevention.,NA,31315304,dhfr 108N,100,100,NA,6.662958860397339,100
Ghana,West Africa,9.56,-0.95,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2017,0.06662958860397339,759,2,Pagaza,2017,2017,dhfr 108N,52,52,52,"Dieng CC, Gonzalez L, Pestana K, Dhikrullahi SB, Amoah LE, Afrane YA, Lo E.",2019,https://www.ncbi.nlm.nih.gov/pubmed/?term=31315304,Contrasting Asymptomatic and Drug Resistance Gene Prevalence of Plasmodium falciparum in Ghana: Implications on Seasonal Malaria Chemoprevention.,NA,31315304,dhfr 108N,100,100,NA,6.662958860397339,100
Ghana,West Africa,5.11,-1.25,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2017,0.13091644644737244,780,3,Cape Coast,2017,2017,dhfr 108N,68,65,65,"Mensah BA, Aydemir O, Myers-Hansen JL, Opoku M, Hathaway NJ, Marsh PW, Anto F, Bailey J, Abuaku B, Ghansah A.",2020,https://pubmed.ncbi.nlm.nih.gov/31932374/,Antimalarial Drug Resistance Profiling of Plasmodium falciparum Infections in Ghana Using Molecular Inversion Probes and Next-Generation Sequencing.,NA,31932374,dhfr 108N,100,100,NA,13.091644644737244,95.58823529411764
Ghana,West Africa,6.75,-1.56,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2017,0.0893012061715126,759,3,Duase,2017,2017,dhfr 108N,52,49,49,"Dieng CC, Gonzalez L, Pestana K, Dhikrullahi SB, Amoah LE, Afrane YA, Lo E.",2019,https://www.ncbi.nlm.nih.gov/pubmed/?term=31315304,Contrasting Asymptomatic and Drug Resistance Gene Prevalence of Plasmodium falciparum in Ghana: Implications on Seasonal Malaria Chemoprevention.,NA,31315304,dhfr 108N,94,94,NA,8.93012061715126,94.23076923076924
Guinea-Bissau,West Africa,11.88,-15.62,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2014,0.04435056075453758,567,1,Bissau,2014,2016,dhfr 108N,316,292,292,"Nag S, Dalgaard MD, Kofoed PE, Ursing J, Crespo M, Andersen LO, Aarestrup FM, Lund O, Alifrangis M",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=28546554,High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing-technology.,NA,28546554,dhfr 108N,92,92,I,4.435056075453758,92.40506329113924
Haiti,Caribbean,18.53,-72.33,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.00592131819576025,510,1,Port-au-Prince,2010,2010,dhfr 108N,108,39,39,"Morton LC, Huber C, Okoth SA, Griffing S, Lucchi N, Ljolje D, Boncy J, Oscar R, Townes D, McMorrow M, Chang MA, Udhayakumar V, Barnwell JW",2016,http://www.ncbi.nlm.nih.gov/pubmed/?term=27430541,"Plasmodium falciparum Drug-Resistant Haplotypes and Population Structure in Postearthquake Haiti, 2010.",NA,27430541,dhfr 108N,36,36,NA,0.592131819576025,36.11111111111111
Haiti,Caribbean,18.4,-73.38,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2016,0.0005093338550068438,783,1,Nippes,2016,2017,dhfr 108N,135,132,132,"Rogier E, Herman C, Huber CS, Hamre KES, Pierre B, Mace KE, Pr?<a9>sum?<a9> J, Mond?<a9>lus G, Romilus I, Elism?<a9> T, Eisele TP, Druetz T, Existe A, Boncy J, Lemoine JF, Udhayakumar V, Chang MA.",2020,https://pubmed.ncbi.nlm.nih.gov/32310062/,"Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016-2017.",NA,32310062,dhfr 108N,98,98,NA,0.05093338550068438,97.77777777777776
Haiti,Caribbean,18.54,-74.16,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2016,0.000580311578232795,783,3,Grand<92>Anse Department,2016,2017,dhfr 108N,150,53,53,"Rogier E, Herman C, Huber CS, Hamre KES, Pierre B, Mace KE, Pr?<a9>sum?<a9> J, Mond?<a9>lus G, Romilus I, Elism?<a9> T, Eisele TP, Druetz T, Existe A, Boncy J, Lemoine JF, Udhayakumar V, Chang MA.",2020,https://pubmed.ncbi.nlm.nih.gov/32310062/,"Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016-2017.",NA,32310062,dhfr 108N,35,35,NA,0.0580311578232795,35.333333333333336
Haiti,Caribbean,18.23,-73.77,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2016,0.0075462497770786285,783,6,Sud Department,2016,2017,dhfr 108N,152,27,27,"Rogier E, Herman C, Huber CS, Hamre KES, Pierre B, Mace KE, Pr?<a9>sum?<a9> J, Mond?<a9>lus G, Romilus I, Elism?<a9> T, Eisele TP, Druetz T, Existe A, Boncy J, Lemoine JF, Udhayakumar V, Chang MA.",2020,https://pubmed.ncbi.nlm.nih.gov/32310062/,"Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, 2016-2017.",NA,32310062,dhfr 108N,18,18,NA,0.7546249777078629,17.763157894736842
India,Asia,24.68,92.56,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2006,0.0006296165520325303,456,2,Hailakandi,2006,2007,dhfr 108N,97,97,97,"Mohapatra PK, Sarma DK, Prakash A, Bora K, Ahmed MA, Sarma B, Goswami BK, Bhattacharyya DR, Mahanta J",2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=25184337,Molecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in North-East India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapy.,NA,25184337,dhfr 108N,100,100,NA,0.06296165520325303,100
India,Asia,27.24,94.11,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2006,0.0012253212044015527,456,1,North Lakhimpur,2006,2007,dhfr 108N,71,71,71,"Mohapatra PK, Sarma DK, Prakash A, Bora K, Ahmed MA, Sarma B, Goswami BK, Bhattacharyya DR, Mahanta J",2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=25184337,Molecular evidence of increased resistance to anti-folate drugs in Plasmodium falciparum in North-East India: a signal for potential failure of artemisinin plus sulphadoxine-pyrimethamine combination therapy.,NA,25184337,dhfr 108N,100,100,NA,0.12253212044015528,100
India,Asia,20.17,84,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2006,0.1005563884973526,444,1,Jharkhand,2006,2012,dhfr 108N,84,55,81,"Sharma D, Lather M, Mallick PK, Adak T, Dang AS, Valecha N, Singh OP",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26381498,Polymorphism in drug resistance genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium falciparum in some states of India.,NA,26381498,dhfr 108N,65,96,NA,10.05563884973526,65.47619047619048
India,Asia,20.95,85.1,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2006,0.0008385946275666356,444,2,Odisha,2006,2012,dhfr 108N,70,43,49,"Sharma D, Lather M, Mallick PK, Adak T, Dang AS, Valecha N, Singh OP",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26381498,Polymorphism in drug resistance genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium falciparum in some states of India.,NA,26381498,dhfr 108N,61,70,NA,0.08385946275666356,61.42857142857143
India,Asia,22.57,88.37,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2008,0.00020423042587935925,524,1,Kolkata,2008,2009,dhfr 108N,176,26,26,"Das S, Chakraborty SP, Hati A, Roy S",2013,http://www.ncbi.nlm.nih.gov/pubmed/?term=23428313,"Malaria treatment failure with novel mutation in the Plasmodium falciparum dihydrofolate reductase (pfdhfr) gene in Kolkata, West Bengal, India.",dhfr 108I identified in 80/176 isolates,23428313,dhfr 108N,15,15,NA,0.02042304258793592,14.772727272727272
India,Asia,21.58,83.53,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2008,0.00015528615040238947,23357175,0,"Sundergarh, Keonjhar, Mayurbhanj, Angul, Kandhamal, Rayagada, Kalahandi, Cuttack",2008,2008,dhfr 108N,201,107,125,Das Sutar SK,2013,http://www.ncbi.nlm.nih.gov/pubmed/23357175,"Molecular monitoring of antimalarial drug resistance among Plasmodium falciparum field isolates from Odisha, India.",NA,23357175,dhfr 108N,53,62,NA,0.01552861504023894,53.233830845771145
India,Asia,23.28,75.53,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2009,0.0004615697544068098,364,1,Ujjain district,2009,2010,dhfr 108N,78,75,75,Pathak A,2014,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4036110&tool=pmcentrez&rendertype=abstract,Characterization of drug resistance associated genetic polymorphisms among Plasmodium falciparum field isolates in Ujjain,NA,24885535,dhfr 108N,96,96,NA,0.04615697544068098,96.15384615384616
India,Asia,19.75,75.71,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2011,0.00008725450607016683,431,1,Maharashtra,2011,2012,dhfr 108N,292,252,252,"Mishra N, Srivastava B, Bharti RS, Rana R, Kaitholia K, Anvikar AR, Das MK, Ghosh SK, Bhatt RM, Tyagi PK, Dev V, Phookan S, Wattal SL, Sonal GS, Dhariwal AC, Valecha N",2016,http://www.ncbi.nlm.nih.gov/pubmed/?term=27353588,Monitoring the efficacy of antimalarial medicines in India via sentinel sites: Outcomes and risk factors for treatment failure.,NA,27353588,dhfr 108N,86,86,NA,0.00872545060701668,86.3013698630137
India,Asia,20.1,80.8,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2013,0.012193728238344193,605,1,Chhattisgarh,2013,2015,dhfr 108N,163,126,126,"Patel P, Bharti PK, Bansal D, Ali NA, Raman RK, Mohapatra PK, Sehgal R, Mahanta J, Sultan AA, Singh N",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=29192183,"Prevalence of mutations linked to antimalarial resistance in Plasmodium falciparum from Chhattisgarh, Central India: A malaria elimination point of view.",NA,29192183,dhfr 108N,77,77,NA,1.2193728238344193,77.30061349693251
India,Asia,22.57,88.37,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2014,0.0003889977524522692,576,1,Kolkata,2014,2016,dhfr 108N,113,107,107,"Chatterjee M, Ganguly S, Saha P, Guha SK, Maji AK",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=28533179,"Polymorphisms in pfdhfr and pfdhps genes after five years of artemisinin combination therapy (ACT) implementation from urban Kolkata, India.",NA,28533179,dhfr 108N,95,95,NA,0.03889977524522692,94.69026548672566
India,Asia,23.33,86.37,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2014,0.0004986166022717953,716,1,"Purulia, Bankura, Midnapore, Kolkata",2014,2016,dhfr 108N,226,213,213,"Das S, Manna S, Saha B, Hati AK, Roy S.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=30535043,Novel pfkelch13 gene polymorphism associates with artemisinin resistance in eastern India.,NA,30535043,dhfr 108N,94,94,NA,0.04986166022717953,94.24778761061948
India,Asia,12.91,74.86,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2014,0.00043168370029889047,812,1,Mangaluru,2014,2014,dhfr 108N,107,76,76,"Jakob Wedam, Costanza Tacoli, Prabhanjan P. Gai, Konrad Siegert, Suyamindra Kulkarni, Rashmi Rasalkar, Animesh Jain, Chakrapani Mahabala, Shantaram Baliga, Damodara Shenoy, Pramod Gai, Rajeshwari Devi, Frank P. Mockenhaupt",2017,NA,"Molecular evidence for plasmodium falciparum resistance to sulfadoxine-pyrimethamine but absence of k13 mutations in mangalore, southern india",NA,NA,dhfr 108N,71,71,NA,0.04316837002988905,71.02803738317756
India,Asia,21.19,81.35,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2015,0.006697996985167265,813,1,"Bhilai, Durg",2015,2017,dhfr 108N,180,159,159,"Sabyasachi Das, Amrita Kar, Subhankar Manna, Samaresh Mandal, Sayantani Mandal, Subhasis Das, Bhaskar Saha & Amiya Kumar Hati",2021,https://doi.org/10.1038/s41598-021-89295-0,Artemisinin combination therapy fails even in the absence of Plasmodium falciparum kelch13 gene polymorphism in Central India,NA,33976269,dhfr 108N,88,88,NA,0.6697996985167265,88.33333333333333
India,Asia,23.28,75.53,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2015,0.000021502861272892915,823,1,Ujjain district,2015,2016,dhfr 108N,104,100,100,"Ashish Pathak , Andreas M<e5>rtensson , Sudhir Gawariker , Ashish Sharma , Vishal Diwan , Manju Purohit , Johan Ursing",2020,NA,"Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4<a0>years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India.",NA,32795288,dhfr 108N,96,96,NA,0.00215028612728929,96.15384615384616
India,Asia,21.67,85.61,NA,NA,NA,2007,NA,492,3,Keonjhar,2007,2007,dhfr 108N,60,60,60,"Srivastava P, Ratha J, Shah NK, Mishra N, Anvikar AR, Sharma SK, Das MK, Srivastava B, Valecha N",2013,http://www.ncbi.nlm.nih.gov/pubmed/?term=23866298,A clinical and molecular study of artesunate + sulphadoxine-pyrimethamine in three districts of central and eastern India.,NA,23866298,dhfr 108N,100,100,NA,NA,100
India,Asia,23.88,91.73,NA,NA,NA,2012,NA,458,1,"Arunal Pradesh, Tripura, Mizoram",2012,2012,dhfr 108N,155,155,155,"Mishra N, Kaitholia K, Srivastava B, Shah NK, Narayan JP, Dev V, Phookan S, Anvikar AR, Rana R, Bharti RS, Sonal GS, Dhariwal AC, Valecha N",2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=25052385,Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India.,NA,25052385,dhfr 108N,100,100,NA,NA,100
India,Asia,21.81,80.18,NA,NA,NA,2012,NA,824,1,"Balaghat and Anuppur, India",2012,2012,dhfr 108N,85,85,85,"Sweta Mishra, Praveen K. Bharti, Man M. Shukla, Nazia A. Ali, Sher S. Kashyotia, Avdhesh Kumar, Akshay C. Dhariwal and Neeru Singh",2017,https://doi.org/10.1080/20477724.2017.1331875,"Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.",NA,28549390,dhfr 108N,100,100,NA,NA,100
India,Asia,18.52,73.86,NA,NA,NA,2012,NA,814,1,Pune,2012,2012,dhfr 108N,63,42,42,"Aarti Ozarkar, Abhishek Kanyal, Swati Dass, Prakash Deshpande, Deepti Deobagkar, Krishanpal Karmodiya",2021,https://www.ias.ac.in/article/fulltext/jbsc/046//0077,"Analysis of drug resistance marker genes of Plasmodium falciparum after implementation of artemisinin-based combination therapy in Pune district, India.",NA,34344849,dhfr 108N,67,67,NA,NA,66.66666666666666
India,Asia,22.21,84.75,NA,NA,NA,2012,NA,821,1,Rourkela,2012,2012,dhfr 108N,55,35,39,"Divya Sharma , Manila Lather , Cherry L Dykes , Amita S Dang , Tridibes Adak , Om P Singh",2016,DOI: 10.1007/s00436-015-4750-2,Disagreement in genotyping results of drug resistance alleles of the Plasmodium falciparum dihydrofolate reductase (Pfdhfr) gene by allele-specific PCR (ASPCR) assays and Sanger sequencing.,DNA sequencing results,26407876,dhfr 108N,64,71,NA,NA,63.63636363636363
India,Asia,21.81,80.18,NA,NA,NA,2013,NA,824,2,"Balaghat and Anuppur, India",2013,2013,dhfr 108N,67,50,50,"Sweta Mishra, Praveen K. Bharti, Man M. Shukla, Nazia A. Ali, Sher S. Kashyotia, Avdhesh Kumar, Akshay C. Dhariwal and Neeru Singh",2017,https://doi.org/10.1080/20477724.2017.1331875,"Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.",NA,28549390,dhfr 108N,100,100,NA,NA,74.6268656716418
India,Asia,28.19,94.17,NA,NA,NA,2013,NA,609,1,Arunachal Pradesh,2013,2013,dhfr 108N,75,75,75,"Sarmah NP, Sarma K, Bhattacharyya DR, Sultan AA, Bansal D, Singh N, Bharti PK, Sehgal R, Mohapatra PK, Parida P, Mahanta J",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=29229871,Antifolate drug resistance: Novel mutations and haplotype distribution in dhps and dhfr from Northeast India.,NA,29229871,dhfr 108N,100,100,NA,NA,100
India,Asia,21.81,80.18,NA,NA,NA,2014,NA,824,3,"Balaghat and Anuppur, India",2014,2014,dhfr 108N,80,5,5,"Sweta Mishra, Praveen K. Bharti, Man M. Shukla, Nazia A. Ali, Sher S. Kashyotia, Avdhesh Kumar, Akshay C. Dhariwal and Neeru Singh",2017,https://doi.org/10.1080/20477724.2017.1331875,"Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.",NA,28549390,dhfr 108N,100,100,NA,NA,6.25
India,Asia,19.49,83.18,NA,NA,NA,2018,NA,825,3,"Kerpai, Orissa",2018,2018,dhfr 108N,100,11,11,"Mary Dias, George D<92>Souza, Aquinas Edassery, Mehul Dhorda",2022,WWARN / St John<92>s Research Institute / Swasthya Swaraj,"Prevalence of molecular markers of antimalarial drug resistance in Plasmodium falciparum isolates collected from two villages in Kalahandi district, Odisha, India",NA,99999999,dhfr 108N,14,14,NA,NA,11
India,Asia,20.15,83.06,NA,NA,NA,2018,NA,825,1,"Kaniguma, Orissa",2018,2018,dhfr 108N,77,9,9,"Mary Dias, George D<92>Souza, Aquinas Edassery, Mehul Dhorda",2022,WWARN / St John<92>s Research Institute / Swasthya Swaraj,"Prevalence of molecular markers of antimalarial drug resistance in Plasmodium falciparum isolates collected from two villages in Kalahandi district, Odisha, India",NA,99999999,dhfr 108N,16,16,NA,NA,11.688311688311687
India,Asia,20.15,83.06,NA,NA,NA,2019,NA,825,2,"Kaniguma, Orissa",2019,2019,dhfr 108N,174,27,27,"Mary Dias, George D<92>Souza, Aquinas Edassery, Mehul Dhorda",2022,WWARN / St John<92>s Research Institute / Swasthya Swaraj,"Prevalence of molecular markers of antimalarial drug resistance in Plasmodium falciparum isolates collected from two villages in Kalahandi district, Odisha, India",NA,99999999,dhfr 108N,16,16,NA,NA,15.517241379310343
Kenya,East Africa,-0.18,34.38,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2001,0.6526237726211548,22096496,2,Asembo,2001,2001,dhfr 108N,242,242,242,"Monica Shah, Simon Kariuki, Jodi Vanden Eng, Anna J. Blackstock, Kimberly Garner, Wangeci Gatei, John E. Gimnig, Kim Lindblade, Dianne Terlouw, Feiko ter Kuile, William A. Hawley, Penelope Phillips-Howard, Bernard Nahlen, Edward Walker, Mary J. Hamel, Laurence Slutsker, Ya Ping Shi",2011,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3214025&tool=pmcentrez&rendertype=abstract,Effect of transmission reduction by insecticide-treated bednets (ITNs) on antimalarial drug resistance in western Kenya.,Post ITN intervention prevalence,22096496,dhfr 108N,100,100,I,65.26237726211548,100
Kenya,East Africa,0.28,34.75,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.6080369353294373,614,5,Kakamega,2003,2003,dhfr 108N,53,53,53,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, Tomás-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic,29363453,dhfr 108N,100,100,NA,60.803693532943726,100
Kenya,East Africa,-0.04,34.55,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.298454612493515,614,2,Kombewa,2005,2005,dhfr 108N,73,73,73,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, Tomás-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic,29363453,dhfr 108N,100,100,NA,29.8454612493515,100
Kenya,East Africa,0.28,34.75,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2005,0.19982437789440155,614,6,Kakamega,2005,2005,dhfr 108N,109,109,109,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, Tomás-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic,29363453,dhfr 108N,100,100,NA,19.982437789440155,100
Kenya,East Africa,-3.63,39.85,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2006,0.04968307167291641,386,6,Kilifi,2006,2007,dhfr 108N,51,51,51,Okombo J,2014,http://www.ncbi.nlm.nih.gov/pubmed/25516825,Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya,Mixed infections excluded,25516825,dhfr 108N,100,100,E,4.968307167291641,100
Kenya,East Africa,-0.04,34.55,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2008,0.17354853451251984,614,3,Kombewa,2008,2008,dhfr 108N,194,164,164,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, Tomás-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic,29363453,dhfr 108N,100,100,NA,17.354853451251984,84.5360824742268
Kenya,East Africa,0.28,34.75,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2008,0.0693601742386818,614,7,Kakamega,2008,2008,dhfr 108N,82,77,77,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, Tomás-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic,29363453,dhfr 108N,100,100,NA,6.936017423868179,93.90243902439023
Kenya,East Africa,0.06,34.28,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.4541771709918976,453,1,Siaya and Bondo District Hospitals,2010,2013,dhfr 108N,201,201,201,"Lucchi NW, Okoth SA, Komino F, Onyona P, Goldman IF, Ljolje D, Shi YP, Barnwell JW, Udhayakumar V, Kariuki S",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=25896703,Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in western Kenya.,NA,25896703,dhfr 108N,100,100,NA,45.41771709918976,100
Kenya,East Africa,-3.22,40.12,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2012,0.007319991942495108,459,17,Malindi,2012,2012,dhfr 108N,52,20,20,"Juma DW, Omondi AA, Ingasia L, Opot B, Cheruiyot A, Yeda R, Okudo C, Cheruiyot J, Muiruri P, Ngalah B, Chebon LJ, Eyase F, Johnson J, Bulimo WD, Akala HM, Andagalu B, Kamau E",2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24989984,Trends in drug resistance codons in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Kenyan parasites from 2008 to 2012.,NA,24989984,dhfr 108N,100,100,NA,0.7319991942495108,38.46153846153847
Kenya,East Africa,-3.63,39.85,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2012,0.025442110374569893,386,7,Kilifi,2012,2013,dhfr 108N,52,52,52,Okombo J,2014,http://www.ncbi.nlm.nih.gov/pubmed/25516825,Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya,Mixed infections excluded,25516825,dhfr 108N,100,100,E,2.5442110374569893,100
Kenya,East Africa,-0.04,34.55,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2015,0.19115862250328064,614,4,Kombewa,2015,2015,dhfr 108N,90,90,90,"Hemming-Schroeder E, Umukoro E, Lo E, Fung B, Tomás-Domingo P, Zhou G, Zhong D, Dixit A, Atieli H, Githeko A, Vardo-Zalik A, Yan G.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=29363453,"Impacts of Antimalarial Drugs on Plasmodium falciparum Drug Resistance Markers, Western Kenya, 2003-2015.",asymptomatic,29363453,dhfr 108N,100,100,NA,19.115862250328064,100
Kenya,East Africa,-0.11,34.89,NA,NA,NA,1992,NA,744,1,Western Kenya,1992,1999,dhfr 108N,145,0,0,"McCollum AM, Schneider KA, Griffing SM, Zhou Z, Kariuki S, Ter-Kuile F, Shi YP, Slutsker L, Lal AA, Udhayakumar V, Escalante AA.",2012,https://www.ncbi.nlm.nih.gov/pubmed/?term=22439637,Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya.,NA,22439637,dhfr 108N,1,1,NA,NA,0
Kenya,East Africa,-0.11,34.89,NA,NA,NA,1992,NA,744,2,Western Kenya,1992,1999,dhfr 108N,205,3,3,"McCollum AM, Schneider KA, Griffing SM, Zhou Z, Kariuki S, Ter-Kuile F, Shi YP, Slutsker L, Lal AA, Udhayakumar V, Escalante AA.",2012,https://www.ncbi.nlm.nih.gov/pubmed/?term=22439637,Differences in selective pressure on dhps and dhfr drug resistant mutations in western Kenya.,NA,22439637,dhfr 108N,1,1,I,NA,1.4634146341463417
Kenya,East Africa,-3.63,39.85,NA,NA,NA,1995,NA,386,4,Kilifi,1995,1995,dhfr 108N,75,59,59,Okombo J,2014,http://www.ncbi.nlm.nih.gov/pubmed/25516825,Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya,Mixed infections excluded,25516825,dhfr 108N,100,100,E,NA,78.66666666666666
Kenya,East Africa,-0.08,34.75,NA,NA,NA,1996,NA,743,1,Nyanza,1996,2000,dhfr 108N,180,176,176,"Iriemenam NC, Shah M, Gatei W, van Eijk AM, Ayisi J, Kariuki S, Vanden Eng J, Owino SO, Lal AA, Omosun YO, Otieno K, Desai M, ter Kuile FO, Nahlen B, Moore J, Hamel MJ, Ouma P, Slutsker L, Shi YP.",2012,https://www.ncbi.nlm.nih.gov/pubmed/?term=22540158,Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.,NA,22540158,dhfr 108N,100,100,NA,NA,97.77777777777776
Kenya,East Africa,-3.63,39.85,NA,NA,NA,1999,NA,386,5,Kilifi,1999,2000,dhfr 108N,62,51,51,Okombo J,2014,http://www.ncbi.nlm.nih.gov/pubmed/25516825,Temporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal Kenya,Mixed infections excluded,25516825,dhfr 108N,100,100,E,NA,82.25806451612904
Kenya,East Africa,-0.08,34.75,NA,NA,NA,2002,NA,743,2,Nyanza,2002,2008,dhfr 108N,176,176,176,"Iriemenam NC, Shah M, Gatei W, van Eijk AM, Ayisi J, Kariuki S, Vanden Eng J, Owino SO, Lal AA, Omosun YO, Otieno K, Desai M, ter Kuile FO, Nahlen B, Moore J, Hamel MJ, Ouma P, Slutsker L, Shi YP.",2012,https://www.ncbi.nlm.nih.gov/pubmed/?term=22540158,Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.,NA,22540158,dhfr 108N,100,100,NA,NA,100
Kenya,East Africa,-0.08,34.75,NA,NA,NA,2008,NA,743,3,Nyanza,2008,2009,dhfr 108N,133,133,133,"Iriemenam NC, Shah M, Gatei W, van Eijk AM, Ayisi J, Kariuki S, Vanden Eng J, Owino SO, Lal AA, Omosun YO, Otieno K, Desai M, ter Kuile FO, Nahlen B, Moore J, Hamel MJ, Ouma P, Slutsker L, Shi YP.",2012,https://www.ncbi.nlm.nih.gov/pubmed/?term=22540158,Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.,NA,22540158,dhfr 108N,100,100,NA,NA,100
Malawi,Southern Africa,-16.02,34.83,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.16472592949867249,555,1,"Chikwawa, Zomba",2010,2012,dhfr 108N,220,220,220,"Ravenhall M, Benavente ED, Mipando M, Jensen AT, Sutherland CJ, Roper C, Sep<fa>lveda N, Kwiatkowski DP, Montgomery J, Phiri KS, Terlouw A, Craig A, Campino S, Ocholla H, Clark TG",2016,http://www.ncbi.nlm.nih.gov/pubmed/?term=27899115,Characterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in Malawi.,Whole genome sequencing,27899115,dhfr 108N,100,100,NA,16.47259294986725,100
Malawi,Southern Africa,-15.77,35.04,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2012,0.13699881732463837,441,1,Ndirande,2012,2012,dhfr 108N,539,537,537,"Artimovich E, Kapito-Tembo A, Pensulo P, Nyirenda O, Brown S, Joshi S, Taylor TE, Mathanga D, Escalante AA, Laufer MK, Takala-Harrison S",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26437774,The effect of local variation in malaria transmission on the prevalence of sulfadoxine-pyrimethamine resistant haplotypes and selective sweep characteristics in Malawi.,Cross-sectional study,26437774,dhfr 108N,100,100,NA,13.699881732463837,99.62894248608536
Malawi,Southern Africa,-14.22,35.39,NA,NA,NA,2003,NA,531,1,Lungwena,2003,2006,dhfr 108N,88,88,88,"Lin JT, Mbewe B, Taylor SM, Luntamo M, Meshnick SR, Ashorn P",2013,http://www.ncbi.nlm.nih.gov/pubmed/?term=23198734,Increased prevalence of dhfr and dhps mutants at delivery in Malawian pregnant women receiving intermittent preventive treatment for malaria.,NA,23198734,dhfr 108N,100,100,NA,NA,100
Malawi,Southern Africa,-15.06,35.23,NA,NA,NA,2010,NA,537,1,Liwonde,2010,2011,dhfr 108N,214,211,211,"Gutman J, Mwandama D, Wiegand RE, Abdallah J, Iriemenam NC, Shi YP, Mathanga DP, Skarbinski J",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=25962439,"In vivo efficacy of sulphadoxine-pyrimethamine for the treatment of asymptomatic parasitaemia in pregnant women in Machinga District, Malawi.",Baseline samples from study with pregnant women treated with SP,25962439,dhfr 108N,99,99,NA,NA,98.5981308411215
Malawi,Southern Africa,-16.07,35.13,NA,NA,NA,2012,NA,441,1,Thyolo,2012,2012,dhfr 108N,726,711,711,"Artimovich E, Kapito-Tembo A, Pensulo P, Nyirenda O, Brown S, Joshi S, Taylor TE, Mathanga D, Escalante AA, Laufer MK, Takala-Harrison S",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26437774,The effect of local variation in malaria transmission on the prevalence of sulfadoxine-pyrimethamine resistant haplotypes and selective sweep characteristics in Malawi.,Cross-sectional survey,26437774,dhfr 108N,98,98,NA,NA,97.93388429752066
Malawi,Southern Africa,-16.03,34.76,NA,NA,NA,2012,NA,441,1,Chikwawa,2012,2012,dhfr 108N,660,656,656,"Artimovich E, Kapito-Tembo A, Pensulo P, Nyirenda O, Brown S, Joshi S, Taylor TE, Mathanga D, Escalante AA, Laufer MK, Takala-Harrison S",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26437774,The effect of local variation in malaria transmission on the prevalence of sulfadoxine-pyrimethamine resistant haplotypes and selective sweep characteristics in Malawi.,Cross-sectional study,26437774,dhfr 108N,99,99,NA,NA,99.3939393939394
Mali,West Africa,12.38,-5.46,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2012,0.4377366900444031,500,1,Koutiala,2012,2012,dhfr 108N,191,176,176,"Maiga H, Lasry E, Diarra M, Sagara I, Bamadio A, Traore A, Coumare S, Bahonan S, Sangare B, Dicko Y, Diallo N, Tembely A, Traore D, Niangaly H, Dao F, Haidara A, Dicko A, Doumbo OK, Djimde AA",NA,http://www.ncbi.nlm.nih.gov/pubmed/?term=27662368,Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali.,NA,27662368,dhfr 108N,92,92,I,43.77366900444031,92.14659685863874
Mali,West Africa,13.81,-10.83,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2014,0.3585107922554016,572,2,Bafoulabe,2014,2014,dhfr 108N,58,53,53,"Diawara F, Steinhardt LC, Mahamar A, Traore T, Kone DT, Diawara H, Kamate B, Kone D, Diallo M, Sadou A, Mihigo J, Sagara I, Djimde AA, Eckert E, Dicko A",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=28797263,"Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali.",NA,28797263,dhfr 108N,91,91,NA,35.85107922554016,91.3793103448276
Mali,West Africa,12.38,-5.46,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2014,0.3716340959072113,500,2,Koutiala,2014,2014,dhfr 108N,177,144,144,"Maiga H, Lasry E, Diarra M, Sagara I, Bamadio A, Traore A, Coumare S, Bahonan S, Sangare B, Dicko Y, Diallo N, Tembely A, Traore D, Niangaly H, Dao F, Haidara A, Dicko A, Doumbo OK, Djimde AA",NA,http://www.ncbi.nlm.nih.gov/pubmed/?term=27662368,Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali.,NA,27662368,dhfr 108N,92,92,I,37.16340959072113,81.35593220338984
Mali,West Africa,13.29,-4.9,NA,NA,NA,2009,NA,585,1,San,2009,2010,dhfr 108N,130,50,50,"Desai M, Gutman J, Taylor SM, Wiegand RE, Khairallah C, Kayentao K, Ouma P, Coulibaly SO, Kalilani L, Mace KE, Arinaitwe E, Mathanga DP, Doumbo O, Otieno K, Edgar D, Chaluluka E, Kamuliwo M, Ades V, Skarbinski J, Shi YP, Magnussen P, Meshnick S, Ter Kuile FO",2016,http://www.ncbi.nlm.nih.gov/pubmed/?term=26486699,Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight.,Pooled samples.,26486699,dhfr 108N,38,38,I,NA,38.46153846153847
Mauritania,West Africa,16.66,-9.62,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.03889230266213417,564,1,Ayoun el Atrous,2010,2010,dhfr 108N,53,10,17,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",NA,28381273,dhfr 108N,19,32,NA,3.889230266213417,18.867924528301888
Mauritania,West Africa,15.82,-9.41,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.03698550909757614,564,2,Kobenni,2010,2010,dhfr 108N,132,46,60,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",NA,28381273,dhfr 108N,35,45,NA,3.698550909757614,34.84848484848485
Mauritania,West Africa,16.39,-10.16,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.03528710454702377,564,3,Tintane,2010,2010,dhfr 108N,83,27,33,"Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=28381273,"Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.",NA,28381273,dhfr 108N,33,40,NA,3.5287104547023773,32.53012048192771
Mozambique,Southern Africa,-25.27,32.87,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2016,0.04247186705470085,765,1,Palmeira,2016,2016,dhfr 108N,95,95,95,"Smith-Aguasca R, Gupta H, Uberegui E, Maquina M, Saute F, Paaijmans KP, Mayor A, Huijben S.",2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796398/,Mosquitoes as a feasible sentinel group for anti-malarial resistance surveillance by Next Generation Sequencing of Plasmodium falciparum.,Sanger sequencing method data was used.,31623623,dhfr 108N,100,100,NA,4.247186705470085,100
Myanmar,SEA,24.79,97.56,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2009,0.03373168781399727,22898135,0,Lazan City,2009,2009,dhfr 108N,58,36,36,"Fang Huang, Linhua Tang, Henglin Yang, Shuisen Zhou, Xiaodong Sun, Hui Liu",2012,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3492106&tool=pmcentrez&rendertype=abstract,"Therapeutic efficacy of artesunate in the treatment of uncomplicated Plasmodium falciparum malaria and anti-malarial, drug-resistance marker polymorphisms in populations near the China-Myanmar border.",NA,22898135,dhfr 108N,62,62,NA,3.373168781399727,62.06896551724138
Niger,West Africa,17.61,8.08,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2011,0.1759200543165207,615,1,Gabi,2011,2012,dhfr 108N,118,82,82,"Grais RF, Laminou IM, Woi-Messe L, Makarimi R, Bouriema SH, Langendorf C, Amambua-Ngwa A, D'Alessandro U, Guérin PJ, Fandeur T, Sibley CH.",2018,https://www.ncbi.nlm.nih.gov/pubmed/29486766,Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.,NA,29486766,dhfr 108N,69,69,NA,17.59200543165207,69.49152542372882
Nigeria,West Africa,7.4,3.92,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2007,0.3218306005001068,553,2,Ibadan,2007,2008,dhfr 108N,190,189,189,"Oguike MC, Falade CO, Shu E, Enato IG, Watila I, Baba ES, Bruce J, Webster J, Hamade P, Meek S, Chandramohan D, Sutherland CJ, Warhurst D, Roper C",2016,http://www.ncbi.nlm.nih.gov/pubmed/?term=27821281,Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.,"mixed excluded for haplotypes, children",27821281,dhfr 108N,100,100,E,32.18306005001068,99.47368421052632
Nigeria,West Africa,6.32,5.61,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2014,0.26619094610214233,553,4,Benin City,2014,2015,dhfr 108N,79,79,79,"Oguike MC, Falade CO, Shu E, Enato IG, Watila I, Baba ES, Bruce J, Webster J, Hamade P, Meek S, Chandramohan D, Sutherland CJ, Warhurst D, Roper C",2016,http://www.ncbi.nlm.nih.gov/pubmed/?term=27821281,Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.,NA,27821281,dhfr 108N,100,100,NA,26.619094610214233,100
Nigeria,West Africa,6.52,3.38,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2016,0.043989941477775574,627,1,Lagos,2016,2016,dhfr 108N,65,65,65,Kolapo Muyiwa Oyebola,2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=30103683,A barcode of multilocus nuclear DNA identifies genetic relatedness in pre- and post-Artemether/Lumefantrine treated Plasmodium falciparum in Nigeria.,NA,30103683,dhfr 108N,100,100,NA,4.398994147777557,100
Pakistan,Asia,33.73,73.09,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2011,0.0025218299124389887,23988011,0,Multiple,2011,2011,dhfr 108N,171,171,171,Khattak AA,2013,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3765786&tool=pmcentrez&rendertype=abstract,A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan.,Pfcrt flanking microsatellites,23988011,dhfr 108N,100,100,NA,0.25218299124389887,100
Pakistan,Asia,32.72,70.37,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2016,0.001286382437683642,717,1,"Bannu, Hangu, Peshawar, Thall",2016,2017,dhfr 108N,90,90,90,"Yaqoob A, Khattak AA, Nadeem MF, Fatima H, Mbambo G, Ouattara A, Adams M, Zeeshan N, Takala-Harrison S.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=30558587,Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.,NA,30558587,dhfr 108N,100,100,NA,0.1286382437683642,100
Pakistan,Asia,28.64,69.19,NA,NA,NA,2016,NA,717,2,"Sui, Quetta, Deramurad Jamali, Zhob",2016,2017,dhfr 108N,52,52,52,"Yaqoob A, Khattak AA, Nadeem MF, Fatima H, Mbambo G, Ouattara A, Adams M, Zeeshan N, Takala-Harrison S.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=30558587,Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.,NA,30558587,dhfr 108N,100,100,NA,NA,100
Pakistan,Asia,33.57,73.01,NA,NA,NA,2016,NA,717,2,Punjab,2016,2017,dhfr 108N,88,88,88,"Yaqoob A, Khattak AA, Nadeem MF, Fatima H, Mbambo G, Ouattara A, Adams M, Zeeshan N, Takala-Harrison S.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=30558587,Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.,NA,30558587,dhfr 108N,100,100,NA,NA,100
Pakistan,Asia,34.08,71.18,NA,NA,NA,2016,NA,717,1,Khyber Agency,2016,2017,dhfr 108N,57,57,57,"Yaqoob A, Khattak AA, Nadeem MF, Fatima H, Mbambo G, Ouattara A, Adams M, Zeeshan N, Takala-Harrison S.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=30558587,Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.,NA,30558587,dhfr 108N,100,100,NA,NA,100
Papua New Guinea,Oceania,-4.98,145.78,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2006,0.00023434705508407205,405,3,North Coast Madang,2006,2006,dhfr 108N,114,114,114,"Barnadas C, Timinao L, Javati S, Iga J, Malau E, Koepfli C, Robinson LJ, Senn N, Kiniboro B, Rare L, Reeder JC, Siba PM, Zimmerman PA, Karunajeewa H, Davis TM, Mueller I",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26452541,Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New Guinea.,Mixed infections excluded,26452541,dhfr 108N,100,100,E,0.0234347055084072,100
Papua New Guinea,Oceania,-5.23,145.77,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2006,0.000004996203642804176,592,1,Madang,2006,2010,dhfr 108N,70,69,69,"Barnadas C, Senn N, Iga J, Timinao L, Javati S, Malau E, Rarau P, Reeder JC, Siba P, Karunajeewa H, Zimmerman PA, Davis TM, Mueller I",2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=25155586,Plasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New Guinea.,Placebo site entered in Surveyor,25155586,dhfr 108N,99,99,NA,4.996203642804176e-4,98.57142857142858
Papua New Guinea,Oceania,-4.32,143.05,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2006,0.0011193116661161184,405,2,East Sepik Province,2006,2006,dhfr 108N,96,91,91,"Barnadas C, Timinao L, Javati S, Iga J, Malau E, Koepfli C, Robinson LJ, Senn N, Kiniboro B, Rare L, Reeder JC, Siba PM, Zimmerman PA, Karunajeewa H, Davis TM, Mueller I",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26452541,Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New Guinea.,Mixed infections excluded,26452541,dhfr 108N,95,95,E,0.11193116661161184,94.79166666666666
Papua New Guinea,Oceania,-4.98,145.78,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.001182416221126914,405,1,North Coast Madang,2010,2010,dhfr 108N,63,62,62,"Barnadas C, Timinao L, Javati S, Iga J, Malau E, Koepfli C, Robinson LJ, Senn N, Kiniboro B, Rare L, Reeder JC, Siba PM, Zimmerman PA, Karunajeewa H, Davis TM, Mueller I",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26452541,Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New Guinea.,Mixed infections excluded,26452541,dhfr 108N,100,100,E,0.1182416221126914,98.4126984126984
Philippines,SEA,8.82,117.5,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2016,0.014923782087862492,808,1,Rizal,2016,2016,dhfr 108N,123,66,66,"Bareng APN, Grignard L, Reyes R, Fornace K, Spencer F, Macalinao ML, Luchavez J, Espino FE, Drakeley C, Hafalla JCR.",2022,https://pubmed.ncbi.nlm.nih.gov/34883232/,"Prevalence and temporal changes of mutations linked to antimalarial drug resistance in Plasmodium falciparum and Plasmodium vivax in Palawan, Philippines.",NA,34883232,dhfr 108N,54,54,NA,1.4923782087862492,53.65853658536586
Qatar,Asia,25.35,51.18,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2013,null,754,1,Doha,2013,2016,dhfr 108N,108,102,102,Bansal D,2019,https://www.ncbi.nlm.nih.gov/pubmed/?term=31296112,Molecular surveillance of putative drug resistance markers of antifolate and artemisinin among imported Plasmodium falciparum in Qatar.,NA,31296112,dhfr 108N,94,94,NA,NA,94.44444444444444
Rwanda,East Africa,-2.31,30.06,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2015,0.06623948365449905,502,1,Ruhuha,2015,2015,dhfr 108N,190,190,190,"Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N",2016,http://www.ncbi.nlm.nih.gov/pubmed/?term=27647575,Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.,NA,27647575,dhfr 108N,100,100,NA,6.623948365449905,100
Rwanda,East Africa,-2.13,29.31,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2015,0.02504286728799343,502,2,Mubuga,2015,2015,dhfr 108N,189,189,189,"Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N",2016,http://www.ncbi.nlm.nih.gov/pubmed/?term=27647575,Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.,NA,27647575,dhfr 108N,100,100,NA,2.504286728799343,100
Senegal,West Africa,14.79,-16.92,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2008,0.03289664909243584,533,2,Thies,2008,2008,dhfr 108N,93,86,86,"Ndiaye D, Dieye B, Ndiaye YD, Van Tyne D, Daniels R, Bei AK, Mbaye A, Valim C, Lukens A, Mboup S, Ndir O, Wirth DF, Volkman S",2013,http://www.ncbi.nlm.nih.gov/pubmed/?term=24533303,"Polymorphism in dhfr/dhps genes, parasite density and ex vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in Thies, Senegal.",NA,24533303,dhfr 108N,94,94,NA,3.2896649092435837,92.47311827956987
Senegal,West Africa,14.76,-17.37,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2009,0.02514873631298542,22694921,0,Dakar,2009,2010,dhfr 108N,170,139,148,"Nathalie Wurtz, B<e9>caye Fall, Aur<e9>lie Pascual, Silmane Diawara, Kowry Sow, Eric Baret, Bakary Diatta, Khadidiatou B Fall, Pape S Mbaye, Fatou Fall, Yaya Di<e9>m<e9>, Christophe Rogier, Raymond Bercion, S<e9>bastien Briolant, Boubacar Wade, Bruno Pradines",2012,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3470961&tool=pmcentrez&rendertype=abstract,"Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.",NA,22694921,dhfr 108N,82,87,NA,2.514873631298542,81.76470588235294
Senegal,West Africa,14.79,-16.92,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2009,0.02365168184041977,533,3,Thies,2009,2009,dhfr 108N,84,67,67,"Ndiaye D, Dieye B, Ndiaye YD, Van Tyne D, Daniels R, Bei AK, Mbaye A, Valim C, Lukens A, Mboup S, Ndir O, Wirth DF, Volkman S",2013,http://www.ncbi.nlm.nih.gov/pubmed/?term=24533303,"Polymorphism in dhfr/dhps genes, parasite density and ex vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in Thies, Senegal.",NA,24533303,dhfr 108N,94,94,NA,2.365168184041977,79.76190476190477
Senegal,West Africa,14.76,-17.37,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.044083259999752045,23510258,0,Dakar,2010,2011,dhfr 108N,155,127,127,Fall B,2013,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3606842&tool=pmcentrez&rendertype=abstract,"Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.",In vitro,23510258,dhfr 108N,82,82,NA,4.4083259999752045,81.93548387096774
Senegal,West Africa,14.79,-16.92,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.03689536079764366,533,4,Thies,2010,2010,dhfr 108N,94,83,83,"Ndiaye D, Dieye B, Ndiaye YD, Van Tyne D, Daniels R, Bei AK, Mbaye A, Valim C, Lukens A, Mboup S, Ndir O, Wirth DF, Volkman S",2013,http://www.ncbi.nlm.nih.gov/pubmed/?term=24533303,"Polymorphism in dhfr/dhps genes, parasite density and ex vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in Thies, Senegal.",NA,24533303,dhfr 108N,94,94,NA,3.689536079764366,88.29787234042553
Senegal,West Africa,12.57,-12.18,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2011,0.10494758933782578,732,1,Kedougou Region,2011,2011,dhfr 108N,240,94,94,"Ndiaye JLA, Ndiaye Y, Ba MS, Faye B, Ndiaye M, Seck A, Tine R, Thior PM, Atwal S, Beshir K, Sutherland C, Gaye O, Milligan P.",2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415816/pdf/pmed.1002762.pdf,"Seasonal malaria chemoprevention combined with community case management of malaria in children under 10 years of age, over 5 months, in south-east Senegal: A cluster-randomised trial.",NA,30865632,dhfr 108N,39,39,NA,10.494758933782578,39.166666666666664
Senegal,West Africa,14.79,-16.92,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2011,0.031560976058244705,533,5,Thies,2011,2011,dhfr 108N,130,122,122,"Ndiaye D, Dieye B, Ndiaye YD, Van Tyne D, Daniels R, Bei AK, Mbaye A, Valim C, Lukens A, Mboup S, Ndir O, Wirth DF, Volkman S",2013,http://www.ncbi.nlm.nih.gov/pubmed/?term=24533303,"Polymorphism in dhfr/dhps genes, parasite density and ex vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in Thies, Senegal.",NA,24533303,dhfr 108N,94,94,NA,3.1560976058244705,93.84615384615384
Senegal,West Africa,14.76,-17.37,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2013,0.04438228905200958,515,1,Dakar,2013,2014,dhfr 108N,99,87,87,"Boussaroque A, Fall B, Madamet M, Wade KA, Fall M, Nakoulima A, Fall KB, Dionne P, Benoit N, Diatta B, Diem<e9> Y, Wade B, Pradines B",2016,http://www.ncbi.nlm.nih.gov/pubmed/?term=27387549,"Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014.",NA,27387549,dhfr 108N,88,88,NA,4.438228905200958,87.87878787878788
Senegal,West Africa,14.75,-17.4,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2014,0.03427685424685478,570,1,Pikine,2014,2014,dhfr 108N,51,50,51,"Mbaye A, Gaye A, Dieye B, Ndiaye YD, Bei AK, Affara M, Deme AB, Yade MS, Diongue K, Ndiaye IM, Ndiaye T, Sy M, Sy N, Koita O, Krogstad DJ, Volkman S, Nwakanma D, Ndiaye D",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=28615016,"Ex vivo susceptibility and genotyping of Plasmodium falciparum isolates from Pikine, Senegal.",NA,28615016,dhfr 108N,98,100,NA,3.427685424685478,98.0392156862745
Senegal,West Africa,13.86,-14.47,NA,NA,NA,2009,NA,520,1,Tambacound,2009,2009,dhfr 108N,73,53,53,"Ndiaye M, Tine R, Faye B, Ndiaye JL, Lo AC, Sylla K, Abiola A, Dieng Y, Ndiaye D, Hallett R, Gaye O, Alifrangis M",2013,http://www.ncbi.nlm.nih.gov/pubmed/?term=23589534,Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal.,NA,23589534,dhfr 108N,91,91,I,NA,72.6027397260274
Senegal,West Africa,13.86,-14.47,NA,NA,NA,2010,NA,520,2,Tambacound,2010,2010,dhfr 108N,76,69,69,"Ndiaye M, Tine R, Faye B, Ndiaye JL, Lo AC, Sylla K, Abiola A, Dieng Y, Ndiaye D, Hallett R, Gaye O, Alifrangis M",2013,http://www.ncbi.nlm.nih.gov/pubmed/?term=23589534,Selection of antimalarial drug resistance after intermittent preventive treatment of infants and children (IPTi/c) in Senegal.,NA,23589534,dhfr 108N,91,91,I,NA,90.78947368421052
Sierra Leone,West Africa,8.87,-12.04,NA,NA,NA,2016,NA,632,3,Makeni,2016,2016,dhfr 108N,114,114,114,"Smith SJ, Kamara ARY, Sahr F, Samai M, Swaray AS, Menard D, Warsame M.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=29932931,"Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone.",NA,29932931,dhfr 108N,100,100,NA,NA,100
Sierra Leone,West Africa,7.96,-11.74,NA,NA,NA,2016,NA,632,1,Bo,2016,2016,dhfr 108N,117,117,117,"Smith SJ, Kamara ARY, Sahr F, Samai M, Swaray AS, Menard D, Warsame M.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=29932931,"Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone.",NA,29932931,dhfr 108N,100,100,NA,NA,100
Sierra Leone,West Africa,7.86,-11.2,NA,NA,NA,2016,NA,632,2,Kenema,2016,2016,dhfr 108N,64,64,64,"Smith SJ, Kamara ARY, Sahr F, Samai M, Swaray AS, Menard D, Warsame M.",2018,https://www.ncbi.nlm.nih.gov/pubmed/?term=29932931,"Efficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra Leone.",NA,29932931,dhfr 108N,100,100,NA,NA,100
Solomon Islands,Oceania,-8.77,160.7,NA,NA,NA,2008,NA,455,3,Malita Province,2008,2008,dhfr 108N,58,58,58,"Gresty KJ, Gray KA, Bobogare A, Wini L, Taleo G, Hii J, Cheng Q, Waters NC",2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=25311473,Genetic mutations in Plasmodium falciparum and Plasmodium vivax dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) in Vanuatu and Solomon Islands prior to the introduction of artemisinin combination therapy.,NA,25311473,dhfr 108N,100,100,NA,NA,100
South Sudan,East Africa,10.12,32.49,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2009,0.0715441033244133,761,3,Upper Nile,2009,2012,dhfr 108N,73,69,69,"Bakhiet AMA, Abdelraheem MH, Kheir A, Omer S, Gismelseed L, Abdel-Muhsin AA, Naiem A, Al Hosni A, Al Dhuhli A, Al Rubkhi M, Al-Hamidhi S, Gadalla A, Mukhtar M, Sultan AA, Babiker HA.",2019,https://www.ncbi.nlm.nih.gov/pubmed/31369106,Evolution of Plasmodium falciparum drug resistance genes following artemisinin combination therapy in Sudan.,NA,31369106,dhfr 108N,95,95,NA,7.15441033244133,94.52054794520548
Sudan,East Africa,15.45,36.4,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2009,0.010140560567378998,761,4,Kassala City,2009,2012,dhfr 108N,74,68,68,"Bakhiet AMA, Abdelraheem MH, Kheir A, Omer S, Gismelseed L, Abdel-Muhsin AA, Naiem A, Al Hosni A, Al Dhuhli A, Al Rubkhi M, Al-Hamidhi S, Gadalla A, Mukhtar M, Sultan AA, Babiker HA.",2019,https://www.ncbi.nlm.nih.gov/pubmed/31369106,Evolution of Plasmodium falciparum drug resistance genes following artemisinin combination therapy in Sudan.,NA,31369106,dhfr 108N,92,92,NA,1.0140560567378998,91.8918918918919
Sudan,East Africa,14.43,33.08,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2009,0.016649050638079643,761,1,Gezira,2009,2012,dhfr 108N,75,72,72,"Bakhiet AMA, Abdelraheem MH, Kheir A, Omer S, Gismelseed L, Abdel-Muhsin AA, Naiem A, Al Hosni A, Al Dhuhli A, Al Rubkhi M, Al-Hamidhi S, Gadalla A, Mukhtar M, Sultan AA, Babiker HA.",2019,https://www.ncbi.nlm.nih.gov/pubmed/31369106,Evolution of Plasmodium falciparum drug resistance genes following artemisinin combination therapy in Sudan.,NA,31369106,dhfr 108N,96,96,NA,1.6649050638079643,96
Sudan,East Africa,10.66,24.63,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2009,0.03370498865842819,761,2,South Darfur,2009,2012,dhfr 108N,74,73,73,"Bakhiet AMA, Abdelraheem MH, Kheir A, Omer S, Gismelseed L, Abdel-Muhsin AA, Naiem A, Al Hosni A, Al Dhuhli A, Al Rubkhi M, Al-Hamidhi S, Gadalla A, Mukhtar M, Sultan AA, Babiker HA.",2019,https://www.ncbi.nlm.nih.gov/pubmed/31369106,Evolution of Plasmodium falciparum drug resistance genes following artemisinin combination therapy in Sudan.,NA,31369106,dhfr 108N,99,99,NA,3.370498865842819,98.64864864864865
Sudan,East Africa,15.45,36.4,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2011,0.018872899934649467,435,1,Kassala City,2011,2011,dhfr 108N,79,77,77,"Adeel AA, Elnour FA, Elmardi KA, Abd-Elmajid MB, Elhelo MM, Ali MS, Adam MA, Atta H, Zamani G, Warsame M, Barrette A, Mohammady HE, Nada RA",2016,http://www.ncbi.nlm.nih.gov/pubmed/?term=27209063,High efficacy of artemether-lumefantrine and declining efficacy of artesunate<a0>+<a0>sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.,NA,27209063,dhfr 108N,97,97,NA,1.8872899934649467,97.46835443037976
Sudan,East Africa,14.03,35.38,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2011,0.017968235537409782,435,2,Gedaref,2011,2011,dhfr 108N,96,93,93,"Adeel AA, Elnour FA, Elmardi KA, Abd-Elmajid MB, Elhelo MM, Ali MS, Adam MA, Atta H, Zamani G, Warsame M, Barrette A, Mohammady HE, Nada RA",2016,http://www.ncbi.nlm.nih.gov/pubmed/?term=27209063,High efficacy of artemether-lumefantrine and declining efficacy of artesunate<a0>+<a0>sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.,NA,27209063,dhfr 108N,97,97,NA,1.7968235537409782,96.875
Sudan,East Africa,15.45,36.4,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2012,0.02577727474272251,23870667,0,Kassala City,2012,2012,dhfr 108N,59,59,59,Gadalla NB,2013,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3720549&tool=pmcentrez&rendertype=abstract,Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.,Comparing prevalences to previous publication,23870667,dhfr 108N,100,100,NA,2.577727474272251,100
Sudan,East Africa,11.77,34.35,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2015,0.013373000547289848,782,1,Damazin,2015,2016,dhfr 108N,119,116,116,"Mohamed AO, Hussien M, Mohamed A, Suliman A, Elkando NS, Abdelbagi H, Malik EM, Abdelraheem MH, Hamid MMA.",2020,https://pubmed.ncbi.nlm.nih.gov/32070355/,"Assessment of Plasmodium falciparum drug resistance molecular markers from the Blue Nile State, Southeast Sudan.",NA,32070355,dhfr 108N,97,97,NA,1.3373000547289848,97.47899159663864
Sudan,East Africa,15.5,32.43,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2016,0.009571393951773643,761,5,Khartoum,2016,2016,dhfr 108N,57,53,53,"Bakhiet AMA, Abdelraheem MH, Kheir A, Omer S, Gismelseed L, Abdel-Muhsin AA, Naiem A, Al Hosni A, Al Dhuhli A, Al Rubkhi M, Al-Hamidhi S, Gadalla A, Mukhtar M, Sultan AA, Babiker HA.",2019,https://www.ncbi.nlm.nih.gov/pubmed/31369106,Evolution of Plasmodium falciparum drug resistance genes following artemisinin combination therapy in Sudan.,NA,31369106,dhfr 108N,93,93,NA,0.9571393951773643,92.98245614035088
Sudan,East Africa,13.63,33.06,NA,NA,NA,2011,NA,435,3,Sennar,2011,2011,dhfr 108N,98,94,94,"Adeel AA, Elnour FA, Elmardi KA, Abd-Elmajid MB, Elhelo MM, Ali MS, Adam MA, Atta H, Zamani G, Warsame M, Barrette A, Mohammady HE, Nada RA",2016,http://www.ncbi.nlm.nih.gov/pubmed/?term=27209063,High efficacy of artemether-lumefantrine and declining efficacy of artesunate<a0>+<a0>sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.,NA,27209063,dhfr 108N,96,96,NA,NA,95.91836734693877
Sudan,East Africa,13.14,32.64,NA,NA,NA,2011,NA,435,4,Kosti,2011,2011,dhfr 108N,92,84,84,"Adeel AA, Elnour FA, Elmardi KA, Abd-Elmajid MB, Elhelo MM, Ali MS, Adam MA, Atta H, Zamani G, Warsame M, Barrette A, Mohammady HE, Nada RA",2016,http://www.ncbi.nlm.nih.gov/pubmed/?term=27209063,High efficacy of artemether-lumefantrine and declining efficacy of artesunate<a0>+<a0>sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.,NA,27209063,dhfr 108N,91,91,NA,NA,91.30434782608695
Tanzania,East Africa,-6.8,39.28,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2004,0.09699380397796631,528,1,NA,2004,2004,dhfr 108N,415,342,342,"Pearce RJ, Ord R, Kaur H, Lupala C, Schellenberg J, Shirima K, Manzi F, Alonso P, Tanner M, Mshinda H, Roper C, Schellenberg D",2013,http://www.ncbi.nlm.nih.gov/pubmed/?term=23225897,A community-randomized evaluation of the effect of intermittent preventive treatment in infants on antimalarial drug resistance in southern Tanzania.,NA,23225897,dhfr 108N,82,82,NA,9.69938039779663,82.40963855421687
Tanzania,East Africa,-6.8,39.28,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2006,0.08891205489635468,528,1,NA,2006,2006,dhfr 108N,524,186,186,"Pearce RJ, Ord R, Kaur H, Lupala C, Schellenberg J, Shirima K, Manzi F, Alonso P, Tanner M, Mshinda H, Roper C, Schellenberg D",2013,http://www.ncbi.nlm.nih.gov/pubmed/?term=23225897,A community-randomized evaluation of the effect of intermittent preventive treatment in infants on antimalarial drug resistance in southern Tanzania.,NA,23225897,dhfr 108N,82,82,NA,8.891205489635468,35.49618320610687
Tanzania,East Africa,-6.8,39.28,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2007,0.09232383221387863,528,2,NA,2007,2007,dhfr 108N,202,163,163,"Pearce RJ, Ord R, Kaur H, Lupala C, Schellenberg J, Shirima K, Manzi F, Alonso P, Tanner M, Mshinda H, Roper C, Schellenberg D",2013,http://www.ncbi.nlm.nih.gov/pubmed/?term=23225897,A community-randomized evaluation of the effect of intermittent preventive treatment in infants on antimalarial drug resistance in southern Tanzania.,NA,23225897,dhfr 108N,82,82,NA,9.232383221387863,80.6930693069307
Tanzania,East Africa,-10.75,39.62,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.14782343804836273,462,2,Mtwara (Tandahimba and Mtwara-Urban),2010,2011,dhfr 108N,64,62,62,"Matondo SI, Temba GS, Kavishe AA, Kauki JS, Kalinga A, van Zwetselaar M, Reyburn H, Kavishe RA",2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24751352,High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania.,Mixed infections excluded,24751352,dhfr 108N,97,97,E,14.782343804836271,96.875
Tanzania,East Africa,-7.73,38.94,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.1896299421787262,462,1,Coastal Region (Kibiti-Rufiji),2010,2011,dhfr 108N,96,86,86,"Matondo SI, Temba GS, Kavishe AA, Kauki JS, Kalinga A, van Zwetselaar M, Reyburn H, Kavishe RA",2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24751352,High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania.,Mixed infections excluded,24751352,dhfr 108N,90,90,E,18.96299421787262,89.58333333333334
Tanzania,East Africa,-5.38,38.58,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.15199391543865204,462,1,Tanga (Bondo village),2010,2011,dhfr 108N,116,116,116,"Matondo SI, Temba GS, Kavishe AA, Kauki JS, Kalinga A, van Zwetselaar M, Reyburn H, Kavishe RA",2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24751352,High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania.,Mixed infections excluded,24751352,dhfr 108N,100,100,E,15.199391543865204,100
Tanzania,East Africa,-2.41,32.95,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.13028500974178314,22369089,0,Igombe health centre,2010,2011,dhfr 108N,97,92,92,"Erasmus Kamugisha, Sun Jing, Mercy Minde, Johaness Kataraihya, Gilbert Kongola, Fred Kironde,G<f6>te Swedberg",2012,http://www.malariajournal.com/content/11/1/58,"Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania.",Clinical AL data and post-treatment genotypes,22369089,dhfr 108N,95,95,NA,13.028500974178314,94.84536082474226
Tanzania,East Africa,-5.18,38.79,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2013,0.10609590262174606,440,1,Muheza,2013,2013,dhfr 108N,77,76,76,"Baraka V, Ishengoma DS, Fransis F, Minja DT, Madebe RA, Ngatunga D, Van Geertruyden JP",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26542942,High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania.,Cross-sectional surveys,26542942,dhfr 108N,99,99,NA,10.609590262174606,98.7012987012987
Tanzania,East Africa,-1.85,31.66,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2013,0.07633348554372787,440,1,Kagera (Muleba district),2013,2013,dhfr 108N,72,72,72,"Baraka V, Ishengoma DS, Fransis F, Minja DT, Madebe RA, Ngatunga D, Van Geertruyden JP",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26542942,High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania.,Cross-sectional surveys,26542942,dhfr 108N,100,100,NA,7.6333485543727875,100
Tanzania,East Africa,-10.35,38.66,NA,NA,NA,2013,NA,440,2,Nachingwea,2013,2013,dhfr 108N,85,82,82,"Baraka V, Ishengoma DS, Fransis F, Minja DT, Madebe RA, Ngatunga D, Van Geertruyden JP",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26542942,High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania.,Cross-sectional surveys,26542942,dhfr 108N,96,96,NA,NA,96.47058823529412
Uganda,East Africa,0.69,34.18,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2003,0.9998051524162292,24799371,0,Tororo,2003,2003,dhfr 108N,80,80,80,Mbogo GW,2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Previously published genotype data in the art,24799371,dhfr 108N,100,100,NA,99.98051524162292,100
Uganda,East Africa,-0.79,29.92,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2007,0.139617457985878,569,1,Rukungiri,2007,2007,dhfr 108N,139,139,139,"Lynch CA, Pearce R, Pota H, Egwang C, Egwang T, Bhasin A, Cox J, Abeku TA, Roper C",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=28415996,Travel and the emergence of high-level drug resistance in Plasmodium falciparum in southwest Uganda: results from a population-based study.,cross-sectional study,28415996,dhfr 108N,100,100,NA,13.9617457985878,100
Uganda,East Africa,0.69,34.18,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2008,0.5055534243583679,24799371,3,Tororo,2008,2008,dhfr 108N,128,99,128,Mbogo GW,2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes,24799371,dhfr 108N,100,100,NA,50.55534243583679,77.34375
Uganda,East Africa,0.69,34.18,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2009,0.5604692697525024,24799371,4,Tororo,2009,2009,dhfr 108N,93,83,93,Mbogo GW,2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes,24799371,dhfr 108N,100,100,NA,56.04692697525024,89.24731182795699
Uganda,East Africa,0.69,34.18,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.5827106833457947,24799371,5,Tororo,2010,2010,dhfr 108N,111,92,110,Mbogo GW,2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes,24799371,dhfr 108N,100,99,NA,58.27106833457947,82.88288288288288
Uganda,East Africa,0.69,34.18,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2011,0.6074368953704834,24799371,6,Tororo,2011,2011,dhfr 108N,111,101,111,Mbogo GW,2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes,24799371,dhfr 108N,100,100,NA,60.74368953704834,90.990990990991
Uganda,East Africa,-0.82,29.74,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2012,0.07849647104740143,591,4,Kanungu,2012,2012,dhfr 108N,72,72,72,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,NA,28039354,dhfr 108N,100,100,NA,7.849647104740143,100
Uganda,East Africa,0.42,33.2,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2012,0.5073883533477783,591,1,Jinja,2012,2012,dhfr 108N,66,66,66,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,NA,28039354,dhfr 108N,100,100,NA,50.73883533477783,100
Uganda,East Africa,0.69,34.18,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2012,0.6195163130760193,24799371,7,Tororo,2012,2012,dhfr 108N,79,77,79,Mbogo GW,2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24799371,Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda.,Including pre-treatment genotypes + genotypes,24799371,dhfr 108N,100,100,NA,61.95163130760193,97.46835443037976
Uganda,East Africa,0.69,34.18,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2012,0.6195163130760193,591,7,Tororo,2012,2012,dhfr 108N,255,255,255,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,NA,28039354,dhfr 108N,100,100,NA,61.95163130760193,100
Uganda,East Africa,-0.82,29.74,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2013,0.07722874730825424,591,5,Kanungu,2013,2013,dhfr 108N,60,60,60,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,NA,28039354,dhfr 108N,100,100,NA,7.722874730825424,100
Uganda,East Africa,0.69,34.18,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2013,0.5193749666213989,591,8,Tororo,2013,2013,dhfr 108N,198,198,198,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,NA,28039354,dhfr 108N,100,100,NA,51.93749666213989,100
Uganda,East Africa,-0.82,29.74,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2015,0.08142995089292526,591,6,Kanungu,2015,2015,dhfr 108N,110,110,110,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,NA,28039354,dhfr 108N,100,100,NA,8.142995089292526,100
Uganda,East Africa,0.69,34.18,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2015,0.2991955876350403,591,9,Tororo,2015,2015,dhfr 108N,282,282,282,"Tumwebaze P, Tukwasibwe S, Taylor A, Conrad M, Ruhamyankaka E, Asua V, Walakira A, Nankabirwa J, Yeka A, Staedke SG, Greenhouse B, Nsobya SL, Kamya MR, Dorsey G, Rosenthal PJ",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=28039354,Changing Antimalarial Drug Resistance Patterns Identified by Surveillance at Three Sites in Uganda.,NA,28039354,dhfr 108N,100,100,NA,29.91955876350403,100
Uganda,East Africa,0.69,34.18,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2015,0.2991955876350403,573,1,Tororo,2015,2015,dhfr 108N,212,207,207,"Conrad MD, Mota D, Foster M, Tukwasibwe S, Legac J, Tumwebaze P, Whalen M, Kakuru A, Nayebare P, Wallender E, Havlir DV, Jagannathan P, Huang L, Aweeka F, Kamya MR, Dorsey G, Rosenthal PJ",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=28968782,Impact of intermittent preventive treatment during pregnancy on Plasmodium falciparum drug resistance-mediating polymorphisms in Uganda.,NA,28968782,dhfr 108N,98,98,NA,29.91955876350403,97.64150943396226
Uganda,East Africa,0.36,32.75,NA,NA,NA,2010,NA,535,1,Mukono,2010,2012,dhfr 108N,105,105,105,"Mbonye AK, Birungi J, Yanow SK, Shokoples S, Malamba S, Alifrangis M, Magnussen P",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26124154,Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda.,Pregnant women before receiving IPTp presented,26124154,dhfr 108N,100,100,I,NA,100
Yemen,Asia,14.54,44.4,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2010,0.0007708085468038917,329,1,Dhamar,2010,2010,dhfr 108N,108,58,58,Al-Hamidhi S,2013,http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3729657&tool=pmcentrez&rendertype=abstract,Genetic diversity of Plasmodium falciparum and distribution of drug resistance haplotypes in Yemen.,Unclear how mixed infections were presented,23855834,dhfr 108N,54,54,NA,0.07708085468038917,53.70370370370371
Yemen,Asia,15.12,50.47,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2011,0.033005863428115845,439,2,Al-Raydah<96>Qusyer,2011,2012,dhfr 108N,102,88,88,"Bamaga OA, Mahdy MA, Lim YA",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26693691,"Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.",NA,26693691,dhfr 108N,86,86,NA,3.3005863428115845,86.27450980392157
Yemen,Asia,14.8,42.95,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2014,0,434,1,Hodeidah,2014,2014,dhfr 108N,81,53,53,"Atroosh WM, Al-Mekhlafi HM, Snounou G, Al-Jasari A, Sady H, Nasr NA, Lau YL, Surin J",2016,http://www.ncbi.nlm.nih.gov/pubmed/?term=27234587,Sustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytes.,NA,27234587,dhfr 108N,65,65,NA,0,65.4320987654321
Zambia,Southern Africa,-9.35,28.73,Global Pf Parasite Rate,Malaria:202206_Global_Pf_Parasite_Rate,"Proportion of Children 2 to 10 years of age showing, on a given year, detectable Plasmodium falciparum parasite",2013,0.38865596055984497,448,1,Nchelenge,2013,2013,dhfr 108N,72,68,69,"Siame MN, Mharakurwa S, Chipeta J, Thuma P, Michelo C",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=25943379,"High prevalence of dhfr and dhps molecular markers in Plasmodium falciparum in pregnant women of Nchelenge district, Northern Zambia.",pregnant women,25943379,dhfr 108N,94,96,NA,38.8655960559845,94.44444444444444
Zambia,Southern Africa,-11.18,28.89,NA,NA,NA,2010,NA,460,1,Mansa,2010,2011,dhfr 108N,84,84,84,"Tan KR, Katalenich BL, Mace KE, Nambozi M, Taylor SM, Meshnick SR, Wiegand RE, Chalwe V, Filler SJ, Kamuliwo M, Craig AS",2014,http://www.ncbi.nlm.nih.gov/pubmed/?term=24909578,"Efficacy of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, Zambia.",Baseline samples from pregnant women to be treated with IPT,24909578,dhfr 108N,100,100,I,NA,100
S<e9>n<e9>gal,NA,14.75,-17.23,NA,NA,NA,2010,NA,443,2,Thi<e8>s,2010,2010,dhfr 108N,71,68,68,"Papa Mze N, Ndiaye YD, Diedhiou CK, Rahamatou S, Dieye B, Daniels RF, Hamilton EJ, Diallo M, Bei AK, Wirth DF, Mboup S, Volkman SK, Ahouidi AD, Ndiaye D",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=26415927,RDTs as a source of DNA to study Plasmodium falciparum drug resistance in isolates from Senegal and the Comoros Islands.,NA,26415927,dhfr 108N,96,96,NA,NA,95.77464788732394
Somalia,NA,1.81,44.69,NA,NA,NA,2011,NA,457,1,Janale,2011,2011,dhfr 108N,79,79,79,"Warsame M, Hassan AM, Barrette A, Jibril AM, Elmi HH, Arale AM, Mohammady HE, Nada RA, Amran JG, Muse A, Yusuf FE, Omar AS",2015,http://www.ncbi.nlm.nih.gov/pubmed/?term=25583123,Treatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant alleles.,NA,25583123,dhfr 108N,100,100,NA,NA,100
Somalia,NA,11.28,49.18,NA,NA,NA,2015,NA,574,1,Bosaso,2015,2015,dhfr 108N,90,90,90,"Warsame M, Hassan AH, Hassan AM, Arale AM, Jibril AM, Mohamud SA, Barrette A, Muse AY, Yusuf FE, Nada RA, Amran JG",2017,http://www.ncbi.nlm.nih.gov/pubmed/?term=28151566,Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy.,NA,28151566,dhfr 108N,100,100,NA,NA,100
